z*******4
发帖数: 285 | 1 诸位称其为“良心公司”、“人民的希望”的将军们
要不要集体去药厂门口直播自焚？ | S**********p
发帖数: 331 | | z*******4
发帖数: 285 | 3 天下熙熙皆为利往
把一个药厂当成慈善机构，这连5岁的智商都没有吧 | V*****2
发帖数: 7930 | 4 不用自焚，请律师告死GILD公司，让公司被安慰组的病人家属赔钱。 | n********g
发帖数: 6504 | 5 病人或家属自己签的生死状。自愿当人牲为人家钱包做贡献的。
【在 V*****2 的大作中提到】
: 不用自焚，请律师告死GILD公司，让公司被安慰组的病人家属赔钱。
| W*****B
发帖数: 4796 | 6 对照组死了一半病人
治疗组都活下来了
这个实验确实很残忍
但是吉列德公司可赚大发了
【在 z*******4 的大作中提到】
: 诸位称其为“良心公司”、“人民的希望”的将军们
: 要不要集体去药厂门口直播自焚？
| z*******4
发帖数: 285 | 7 病人都签了同意书，咋告？
【在 V*****2 的大作中提到】
: 不用自焚，请律师告死GILD公司，让公司被安慰组的病人家属赔钱。
| z*******4
发帖数: 285 | 8 病人到死都不知道自己是不是对照组
冤不冤？
但这就是现实，长期看，有它的合理性
对于短期爆发性疾病，这套流程并不合适
【在 W*****B 的大作中提到】
: 对照组死了一半病人
: 治疗组都活下来了
: 这个实验确实很残忍
: 但是吉列德公司可赚大发了
| V*****2
发帖数: 7930 | 9 还是应该可以告的，因为病人和病人家属并不懂得原理，属于欺诈行为。因为药物试验
可以使用比较试验，而不是用安慰剂做试验。
在任何有欺诈行为的情况下，尤其是直接危害病人生命的时候，签下的合同无效。这在
法律里讲得很清楚的。
【在 n********g 的大作中提到】
: 病人或家属自己签的生死状。自愿当人牲为人家钱包做贡献的。
| b*******8
发帖数: 37364 | 10 终南山既然这么说，估摸八九不离十就是Placebo了。在中国做测试，怎么做，不可能
瞒着中国政府和机构的。 | | | n********g
发帖数: 6504 | 11 而且十有八九药效比不过其它药
【在 b*******8 的大作中提到】
: 终南山既然这么说，估摸八九不离十就是Placebo了。在中国做测试，怎么做，不可能
: 瞒着中国政府和机构的。
| z*******4
发帖数: 285 | 12 病人连自己是不是对照组都不知道，怎么告？
而且他们签字的同意书里，都放弃了许多的权利：
比如知道自己是药物组还是placebo组的权利；
比如治疗期间，选择其他药物治疗的权利；
比如治疗失败后，向药厂、医院索赔的权利。。。
简单来说，签了同意书，就是把命卖给药厂了
所以要找病人进组做临床实验，得忽悠，加大劲忽悠
但往往忽悠也凑不齐有脑子的病人
轮子这种脑子被活摘的病人，可能特别容易忽悠进组。
【在 V*****2 的大作中提到】
: 还是应该可以告的，因为病人和病人家属并不懂得原理，属于欺诈行为。因为药物试验
: 可以使用比较试验，而不是用安慰剂做试验。
: 在任何有欺诈行为的情况下，尤其是直接危害病人生命的时候，签下的合同无效。这在
: 法律里讲得很清楚的。
| s********i
发帖数: 17328 | 13 咋还令不清呢？没有药的情况下，你吃placebo不增加你的倒霉程度，你有啥不满的？
自己同意碰大运而已。 | V*****2
发帖数: 7930 | 14 因为不知道，所以可以团体告，哪怕用的是好药，因为不知情，被冒了不必要的风险，
一样是可以告的。
这是有先例的，辉瑞制药，前些年，在非洲做药物试验，出了大问题。因此被告上法庭
，是非洲的政府出面告的，要辉瑞制药赔钱。但是辉瑞制药拒绝赔钱。这是非常有名气
的案子，你去搜一下，应该搜得到的。
中国不一样，GILD在中国一样有BUSINESS，可以在中国打官司。一旦病人胜诉，可以直
接从GILD公司在中国的BUSINESS里面扣钱。
【在 z*******4 的大作中提到】
: 病人连自己是不是对照组都不知道，怎么告？
: 而且他们签字的同意书里，都放弃了许多的权利：
: 比如知道自己是药物组还是placebo组的权利；
: 比如治疗期间，选择其他药物治疗的权利；
: 比如治疗失败后，向药厂、医院索赔的权利。。。
: 简单来说，签了同意书，就是把命卖给药厂了
: 所以要找病人进组做临床实验，得忽悠，加大劲忽悠
: 但往往忽悠也凑不齐有脑子的病人
: 轮子这种脑子被活摘的病人，可能特别容易忽悠进组。
| z*******4
发帖数: 285 | 15 问题是，有其他药啊
关于新冠肺炎，已经上临床的西药就有十几种
瑞德西尾只是其中之一
如果进组了，就等于放弃了用其他药物的权利。
从药厂的角度考虑，当然是双盲实验好，结果显著，就能得到FDA批准，然后上市卖高
价。
从病人角度考虑，当然要放弃双盲实验，病人自愿加入不同药物的实验组，如果病情没
有控制，就可以立刻改用其他药物治疗，最大可能挽救性命。
而病人进入双盲实验后，不但不可以用其他药物治疗，甚至连自己是不是吃placebo都
不知道。
【在 s********i 的大作中提到】
: 咋还令不清呢？没有药的情况下，你吃placebo不增加你的倒霉程度，你有啥不满的？
: 自己同意碰大运而已。
| s********i
发帖数: 17328 | 16 哪有其他药（不是治其他病的药，是治辽新冠的药）？都是谣传。。。世卫组织和中国
卫生部都明确说了没有药治疗新冠。。。因为第一个药一定是来自双盲实验。没有双盲
实验，都是扯淡啊。。。你说你吃这药好了，就算有效了？
【在 z*******4 的大作中提到】
: 问题是，有其他药啊
: 关于新冠肺炎，已经上临床的西药就有十几种
: 瑞德西尾只是其中之一
: 如果进组了，就等于放弃了用其他药物的权利。
: 从药厂的角度考虑，当然是双盲实验好，结果显著，就能得到FDA批准，然后上市卖高
: 价。
: 从病人角度考虑，当然要放弃双盲实验，病人自愿加入不同药物的实验组，如果病情没
: 有控制，就可以立刻改用其他药物治疗，最大可能挽救性命。
: 而病人进入双盲实验后，不但不可以用其他药物治疗，甚至连自己是不是吃placebo都
: 不知道。
| z*******4
发帖数: 285 | 17 签名栏上最醒目的一句话就是：
我已经阅读并十分了解此合同中的内容。。。
用“不知道”为由控告，药厂不会败诉。
药厂养多少律师，你以为连临床实验一份模式的同意书都有漏洞？
美国中国每年临床实验死多少人？有能告赢药厂的么？
【在 V*****2 的大作中提到】
: 因为不知道，所以可以团体告，哪怕用的是好药，因为不知情，被冒了不必要的风险，
: 一样是可以告的。
: 这是有先例的，辉瑞制药，前些年，在非洲做药物试验，出了大问题。因此被告上法庭
: ，是非洲的政府出面告的，要辉瑞制药赔钱。但是辉瑞制药拒绝赔钱。这是非常有名气
: 的案子，你去搜一下，应该搜得到的。
: 中国不一样，GILD在中国一样有BUSINESS，可以在中国打官司。一旦病人胜诉，可以直
: 接从GILD公司在中国的BUSINESS里面扣钱。
| g*q
发帖数: 26623 | 18 多的是部分有效的药
【在 s********i 的大作中提到】
: 咋还令不清呢？没有药的情况下，你吃placebo不增加你的倒霉程度，你有啥不满的？
: 自己同意碰大运而已。
| z*******4
发帖数: 285 | 19 算了，你脑子大概也被活摘过
懒得跟你解释，贴个清单吧：
累计研究数量 注册号 注册日期 研究者单位 研究者单位（英文） 注
册题目 注册题目（英文) 预计纳入参试者日期
1 ChiCTR2000029308 1/23/2020 武汉市金银潭医院（武汉市传染病医院）
Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital) 一项评价
洛匹那韦/利托那韦和干扰素-α2b联合治疗武汉新型冠状病毒肺炎(COVID-19)住院患者
的疗效和安全性随机、开放、空白对照的研究 A randomized, open-label, blank-
controlled trial for the efficacy and safety of lopinavir-ritonavir and
interferon-alpha 2b in hospitalization patients with novel coronavirus
pneumonia (COVID-19) 1/10/2020
2 ChiCTR2000029381 1/27/2020 广州医科大学附属第一医院 The First
Affiliated Hospital of Guangzhou Medical University 血必净注射液治疗新型
冠状病毒肺炎(COVID-19)疗效的前瞻性对照研究 A prospective comparative
study for Xue-Bi-Jing injection in the treatment of novel coronavirus
pneumonia (COVID-19) 1/24/2020
3 ChiCTR2000029386 1/28/2020 重庆市公共卫生医疗救治中心
Chongqing Public Health Medical Center 糖皮质激素治疗重度新型冠状病毒肺炎
(COVID-19)的随机对照研究 Adjunctive Corticosteroid Therapy for Patients
with Severe Novel Coronavirus Pneumonia (COVID-19): a Randomized Controlled
Trial 1/29/2020
4 ChiCTR2000029387 1/28/2020 重庆市公共卫生医疗救治中心
Chongqing Public Health Medical Center 轻中度新型冠状病毒肺炎(COVID-19)治
疗策略随机对照研究 Comparison of efficacy and safety of three antiviral
regimens in patients with mild to moderate novel coronavirus pneumonia (
COVID-19): a randomized controlled trial 1/25/2020
5 ChiCTR2000029400 1/29/2020 中国中医科学院 China Academy of
Chinese Medical Sciences 中医药治疗新型冠状病毒肺炎(COVID-19)临床对照研究
Clinical Controlled Trial for Traditional Chinese Medicine in the
treatment of Novel Coronavirus Pneumonia (COVID-19) 1/29/2020
6 ChiCTR2000029418 1/30/2020 北京中医药大学东直门医院 Dongzhimen
Hospital Affiliated to Beijing University of Chinese Medicine 中药治疗新
型冠状病毒感染肺炎(COVID-19)重型患者随机对照试验 Chinese Herbal medicine
for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled
Trial 2/3/2020
7 ChiCTR2000029430 2/1/2020 天津中医药大学/湖北省中西医结合医院
Hubei Integrated Hospital of Traditional Chinese and Western Medicine 新
型冠状病毒(COVID-19)肺炎中医证候流行病学研究 Study for the TCM syndrome
characteristics of novel coronavirus pneumonia (COVID-19) 2/3/2020
8 ChiCTR2000029431 2/1/2020 大连大学附属中山医院 Affiliated
Zhongshan Hospital of Dalian University 以巨噬细胞为靶点抗新型冠状病毒肺
炎(COVID-19)治疗方法的临床研究 Clinical study for the remedy of M1
macrophages target in the treatment of novel coronavirus pneumonia (COVID-19
) 1/29/2020
9 ChiCTR2000029432 2/1/2020 广州中医药大学第一附属医院 The First
Afflicated Hospital of Guangzhou University of Chinese Medicine 大剂量痰
热清注射液治疗新型冠状病毒肺炎(COVID-19)真实世界临床研究 A Real World
Study for the Efficacy and Safety of Large Dose Tanreqing Injection in the
Treatment of Patients with Novel Coronavirus Pneumonia (COVID-19) 2/1/
2020
10 ChiCTR2000029433 2/1/2020 河北以岭医院/武汉大学人民医院 Hebei
Yiling Hospital, Renmin Hospital of Wuhan University 连花清瘟胶囊/颗粒治
疗新型冠状病毒肺炎(COVID-19)疑似病例随机、对照临床试验 A randomized, open
-label, blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the
treatment of suspected novel coronavirus pneumonia (COVID-19) 2/1/2020
11 ChiCTR2000029434 2/1/2020 河北以岭医院/武汉大学人民医院 Hebei
Yiling Hospital, Renmin Hospital of Wuhan University 连花清瘟胶囊/颗粒治
疗新型冠状病毒肺炎(COVID-19)随机、对照临床试验 A randomized, open-label,
blank-controlled trial for Lian-Hua Qing-Wen Capsule/Granule in the
treatment of novel coronavirus pneumonia (COVID-19) 2/1/2020
12 ChiCTR2000029435 2/1/2020 武汉市第一医院 Wuhan 1st Hospital
中医药预防新型冠状病毒肺炎(COVID-19)的随机对照试验 Randomized
controlled trial for traditional Chinese medicine in the prevention of novel
coronavirus pneumonia (COVID-19) in high risk population 2/1/2020
13 ChiCTR2000029436 2/1/2020 河南中医药大学第一附属医院 The
First Hospital of He'nan University of Chinese Medicine 新型冠状病毒肺炎(
COVID-19)中西医结合治疗方案的疗效评价 A single arm study for evaluation
of integrated traditional Chinese and western medicine in the treatment of
novel coronavirus pneumonia (COVID-19) 2/1/2020
14 ChiCTR2000029437 2/1/2020 湖北省中西医结合医院/天津中医药大学
Hubei Provincial Integrated Hospital of traditional Chinese and Western
Medicine 中西医结合治疗新型冠状病毒肺炎(COVID-19)的单队列研究 A single
arm study for combination of traditional Chinese and Western Medicine in
the treatment of novel coronavirus pneumonia (COVID-19) 2/3/2020
15 ChiCTR2000029438 2/1/2020 天津中医药大学/北京中医医院 Beijing
hospital of Traditional Chinese medicine; Hubei integrated traditional
Chinese and Western Medicine Hospital 中西医结合对新型冠状病毒(COVID-19)
重症肺炎临床试验 A randomized controlled trial of integrated TCM and
Western Medicine in the treatment of severe 2019-nCoV pneumonia (novel
coronavirus pneumonia, NCP) 2/4/2020
16 ChiCTR2000029439 2/1/2020 天津中医药大学/北京中医医院；武汉市中
医院 Beijing Hospital of Traditional Chinese Medicine affiliated to
Capital Medical University/Beijing institute of Traditional Chinese MedHubei
integrated traditional Chinese and Western Medicine Hospital 中西医结合
治疗普通型新型冠状病毒肺炎(COVID-19)临床试验 Combination of traditional
chinese medicne and western medicine in the treatment of common type 2019-
nCoV pneumonia (novel coronavirus pneumonia, NCP) 2/2/2020
17 ChiCTR2000029459 2/2/2020 1.湖北中医药大学附属新华医院4.湖北省中
西医结合医院 1.Xinhua affiliated hospital, Hubei University of Chinese
Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western
Medicine 肺康复对新型冠状病毒肺炎(COVID-19)患者康复期肺功能及生存质量的影
响 The effect of pulmonary rehabilitation for pulmonary function and
quality of life in patients with 2019-nCoV pneumonia (novel coronavirus
pneumonia, NCP) in rehabilitation period 2/3/2020
18 ChiCTR2000029460 2/2/2020 1.湖北中医药大学附属新华医院3.湖北省中
西医结合医院 1. Xinhua affiliated hospital, Hubei University of Chinese
Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western
Medicine 太极拳对新型冠状病毒肺炎(COVID-19)患者康复期肺功能及生存质量影响
的随机对照研究 The effect of shadowboxing for pulmonary function and
quality of life in patients with 2019-nCoV pneumonia (novel coronavirus
pneumonia, NCP) in rehabilitation period 2/2/2020
19 ChiCTR2000029461 2/2/2020 1.湖北中医药大学附属新华医院2.湖北省中
西医结合医院 1. Xinhua affiliated hospital, Hubei University of Chinese
Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western
Medicine 中西医结合治疗方案对普通型新型冠状病毒肺炎(COVID-19)的临床随机对
照研究 A Randomized Controlled Trial for Integrated Traditional Chinese
Medicine and Western Medicine in the Treatment of Common Type 2019-nCoV
Pneumonia (Novel Coronavirus Pneumonia, NCP) 2/3/2020
20 ChiCTR2000029462 2/2/2020 河南中医药大学第一附属医院 The
First Affiliated Hospital of He'nan University of Chinese Medicine 新型冠
状病毒肺炎(COVID-19)的临床特征与证候规律研究 Study for clinical
characteristics and distribution of TCM syndrome of 2019-nCoV pneumonia (
novel coronavirus pneumonia, NCP) 2/1/2020
21 ChiCTR2000029468 2/2/2020 四川省医学科学院·四川省人民医院
Institute of Emergency Medicine and Disaster Medicine Sichuan People's
Hospital, Sichuan Academy of Medical Sciences 洛匹那韦/利托那韦(LPV/r)+恩
曲他滨（FTC）/丙酚替诺福韦（TAF）用于治疗新型冠状病毒肺炎(COVID-19)的临床研
究 A real-world study for lopinavir/ritonavir (LPV/r) and emtritabine (
FTC) / Tenofovir alafenamide Fumarate tablets (TAF) regimen in the treatment
of 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP) 2/1/2020
22 ChiCTR2000029479 2/2/2020 成都中医药大学附属医院 Hospital of
Chengdu University of Traditional Chinese Medicine 新型冠状病毒肺炎(COVID
-19)疫情下社区人群中医药技术防控方案 Research for Traditional Chinese
Medicine Technology Prevention and Control of 2019-nCoV Pneumonia (Novel
Coronavirus Pneumonia, NCP) in the Community Population 1/30/2020
23 ChiCTR2000029487 2/2/2020 武汉市中西医结合医院 Wuhan Hospital
of Integrated Traditional Chinese and Western Medicine 固表解毒灵预防儿
童新型冠状病毒肺炎(COVID-19)的临床研究 Clinical Study for Gu-Biao Jie-Du-
Ling in Preventing of 2019-nCoV Pneumonia (Novel Coronavirus Pneumonia, NCP)
in Children 2/10/2020
24 ChiCTR2000029493 2/2/2020 1.湖北中医药大学附属新华医院3.湖北省中
西医结合医院 1. Xinhua affiliated hospital, Hubei University of Chinese
Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western
Medicine 中药对新型冠状病毒肺炎(COVID-19)患者康复期肺纤维化、肺功能及生存
质量影响的随机对照研究 Traditional Chinese Medicine for Pulmonary
Fibrosis, Pulmonary Function and Quality of Life in Patients With 2019-nCoV
Pneumonia (Novel Coronavirus Pneumonia, NCP) in Convalescent Period: a
Randomized Controlled Trial 2/3/2020
25 ChiCTR2000029495 2/2/2020 1.湖北中医药大学附属新华医院2.湖北省中
西医结合医院 1. Xinhua Affiliated Hospital, Hubei University of Chinese
Medicine; 2. Hubei Provincial Hospital of Integrated Chinese and Western
Medicine 新型冠状病毒肺炎(COVID-19)患者出院后心理健康状况和心理需求调查及
中医药和心理干预研究 Traditional Chinese Medicine, Psychological
Intervention and Investigation of Mental Health for Patients With 2019-nCoV
Pneumonia (Novel Coronavirus Pneumonia, NCP) in Convalescent Period 2/3/
2020
26 ChiCTR2000029496 2/3/2020 中南大学湘雅二医院 The First
Hospital of Changsha; The Second Xiangya Hospital of Central South
University 一项评价重组细胞因子基因衍生蛋白注射液清除新型冠状病毒(COVID-
19)的随机、开放、平行对照研究 A randomized, open label, parallel
controlled trial for evaluating the efficacy of recombinant cytokine gene-
derived protein injection in eliminating novel coronavirus in patients with
2019-nCoV pneumonia (novel coronavirus pneumonia, NCP) 1/29/2020
27 ChiCTR2000029517 2/3/2020 浙江中医药大学 Zhejiang Chinese
Medical University 中医防治疑似新型冠状病毒肺炎(COVID-19)的前瞻性随机双盲
安慰剂对照研究 Chinese medicine prevention and treatment program for
suspected 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP): a
perspective, double-blind, placebo, randomised controlled trial 2/4/2020
28 ChiCTR2000029518 2/3/2020 浙江中医药大学 Zhejiang Chinese
Medical University 中医分期方案治疗新型冠状病毒肺炎(COVID-19)的前瞻性随机
双盲安慰剂对照研究 Chinese medicine prevention and treatment program for
2019-nCoV pneumonia (novel coronavirus pneumonia, NCP): a perspective,
double-blind, placebo, randomised controlled trial 2/4/2020
29 ChiCTR2000029539 2/3/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital, Tongji Medical College, Huazhong University of Science and
Technology 洛匹那韦/利托那韦治疗武汉新型冠状病毒肺炎(COVID-19)轻症患者的
疗效和安全性随机、开放、对照的研究 A randomized, open-label study to
evaluate the efficacy and safety of Lopinavir-Ritonavir in patients with
mild 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP) 2/4/2020
30 ChiCTR2000029541 2/3/2020 武汉大学中南医院 Zhongnan Hospital
of Wuhan University 达芦那韦/考比司他或洛匹那韦/利托那韦片联合胸腺肽a1联
合治疗新型冠状病毒肺炎(COVID-19)的随机、开放、对照临床研究 A randomised,
open, controlled trial for darunavir/cobicistat or Lopinavir/ritonavir
combined with thymosin a1 in the treatment of 2019-nCoV pneumonia (novel
coronavirus pneumonia, NCP) 2/10/2020
31 ChiCTR2000029542 2/3/2020 中山大学孙逸仙纪念医院 Sun Yat sen
Memorial Hospital of Sun Yat sen University 氯喹对2019新型冠状病毒肺炎(
COVID-19)的临床疗效评价 Study for the efficacy of chloroquine in patients
with 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP) 2/3/2020
32 ChiCTR2000029544 2/3/2020 浙江大学医学院附属第一医院 The
First Hospital Affiliated to Zhejiang University's Medical School 在接受
当前抗病毒治疗下仍持续检出病毒阳性的新型冠状病毒肺炎(COVID-19)患者中加用巴洛
沙韦酯片或法匹拉韦片的疗效和安全性的随机、对照临床研究 A randomized
controlled trial for the efficacy and safety of Baloxavir Marboxil,
Favipiravir tablets in 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP
) patients who are still positive on virus detection under the current
antiviral therapy 2/4/2020
33 ChiCTR2000029548 2/4/2020 浙江大学医学院附属第一医院 The
First Affiliated Hospital, Zhejiang University School of Medicine 巴洛沙
韦酯、法匹拉韦对比洛匹那韦/利托那韦（克力芝）在新型冠状病毒肺炎(COVID-19)患
者中的疗效和安全性的随机、对照临床研究 Randomized, open-label, controlled
trial for evaluating of the efficacy and safety of Baloxavir Marboxil,
Favipiravir, and Lopinavir-Ritonavir in the treatment of 2019-nCoV pneumonia
(novel coronavirus pneumonia, NCP) patients 2/4/2020
34 ChiCTR2000029549 2/4/2020 成都中医药大学附属医院 Hospital of
Chengdu University of Traditional Chinese Medicine 新型冠状病毒肺炎(COVID
-19)中西医结合治疗建议方案 Recommendations of Integrated Traditional
Chinese and Western Medicine for 2019-nCoV Pneumonia (Novel Coronavirus
Pneumonia, NCP) 2/3/2020
35 ChiCTR2000029550 2/4/2020 成都中医药大学附属医院 Hospital of
Chengdu University of Traditional Chinese Medicine 新型冠状病毒肺炎(COVID
-19)疫情下成都中医药大学附属医院感冒患者诊疗建议方案 Recommendations for
Diagnosis and Treatment of Influenza Patients in the Hospital of Chengdu
University of Traditional Chinese Medicine Under the Raging of 2019-nCoV
Pneumonia (Novel Coronavirus Pneumonia, NCP) 1/29/2020
36 ChiCTR2000029558 2/4/2020 成都中医药大学附属医院 Hospital of
Chengdu University of Traditional Chinese Medicine 四川省新型冠状病毒肺炎
(COVID-19)中西医结合治疗推荐诊疗方案 Recommendations of Integrated
Traditional Chinese and Western Medicine for Diagnosis and Treatment of 2019
-nCoV Pneumonia (Novel Coronavirus Pneumonia, NCP) in Sichuan Province 1/
29/2020
37 ChiCTR2000029559 2/4/2020 武汉大学人民医院 Renmin Hospital of
Wuhan University 羟氯喹对新型冠状病毒肺炎(COVID-19)的治疗疗效研究
Therapeutic effect of hydroxychloroquine on 2019-nCoV pneumonia (novel
coronavirus pneumonia, NCP) 1/31/2020
38 ChiCTR2000029569 2/4/2020 襄阳市第一人民医院 Xiangyang 1st
People's Hospital 脐带间充干细胞条件培养基治疗重症及危重症新型冠状病毒肺
炎(COVID-19)的安全性和有效性研究：随机对照临床试验 Safety and efficacy of
umbilical cord blood mononuclear cells conditioned medium in the treatment
of severe and critically 2019-nCoV pneumonia (novel coronavirus pneumonia,
NCP): a randomized controlled trial 2/5/2020
39 ChiCTR2000029572 2/5/2020 襄阳市第一人民医院 Xiangyang First
People's Hospital 脐带血单个核细胞治疗重症及危重症新型冠状病毒肺炎(COVID-
19)的安全性和有效性研究：随机临床对照试验 Safety and efficacy of
umbilical cord blood mononuclear cells in the treatment of severe and
critically 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP): a
randomized controlled clinical trial 2/5/2020
40 ChiCTR2000029573 2/4/2020 浙江大学医学院附属第一医院 The
First Affiliated Hospital of Medical College of Zhejiang University 评价
重组细胞因子基因衍生蛋白注射液联合阿比多尔、洛匹那韦/利托那韦在新型冠状病毒
肺炎(COVID-19)患者中的有效性和安全性的多中心、随机、开放性、阳性对照临床研究
A multicenter, randomized, open-label, positive-controlled trial for the
efficacy and safety of recombinant cytokine gene-derived protein injection
combined with abidole, lopinavir/litonavir in the treatment of 2019-nCoV
pneumonia (novel coronavirus pneumonia, NCP) patients 2/6/2020
41 ChiCTR2000029578 2/5/2020 浙江中医药大学 Zhejiang Chinese
Medical University 中医防治新型冠状病毒肺炎(COVID-19)的单臂研究
Chinese medicine prevention and treatment program for 2019-nCoV pneumonia (
novel coronavirus pneumonia, NCP): a perspective, sing-arm trial 2/6/2020
42 ChiCTR2000029579 2/5/2020 华中科技大学同济医学院附属同济医院
Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong
University of Science and Technology 新型冠状病毒肺炎细胞因子表达谱分析及
临床意义研究 Cytokines profiling and their clinical significance analysis
of 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP) patients 1/31/
2020
43 ChiCTR2000029580 2/5/2020 华中科技大学同济医学院附属同济医院血液
内科 Department of Hematology, Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology 芦可替尼联合输注间充质干细
胞治疗重症新型冠状病毒肺炎患者的前瞻性、单盲、随机对照临床研究 A
prospective, single-blind, randomized controlled trial for Ruxolitinib
combined with mesenchymal stem cell infusion in the treatment of patients
with severe 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP) 1/31/
2020
44 ChiCTR2000029589 2/5/2020 北京中医医院/天津中医药大学 Beijing
hospital of Traditional Chinese Medicine; Hubei Integrated Traditional
Chinese and Western Medicine Hospital 热毒宁注射液治疗新型冠状病毒肺炎有
效性和安全性的开放性、前瞻性、多中心临床研究 An open, prospective,
multicenter clinical study for the efficacy and safety of Reduning injection
in the treatment of 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP)
2/6/2020
45 ChiCTR2000029592 2/5/2020 华中科技大学同济医学院附属协和医院
Union Hospital, Tongji Medical College, Huazhong University of Science and
Technology 阿比多尔用于新型冠状病毒(COVID-19)高暴露风险人群暴露后预防的临
床研究 Study for Arbidol Hydrochloride in the Prophylaxis of Novel
Coronavirus Infection in High-risk Population with History of Exposed to
2019-nCoV pneumonia 2/7/2020
46 ChiCTR2000029600 2/6/2020 深圳市第三人民医院 The Third People
's Hospital of Shenzhen 法匹拉韦治疗新型冠状病毒肺炎(COVID-19)患者的安全
性和有效性的临床研究 Clinical study for safety and efficacy of
Favipiravir in the treatment of 2019-nCoV pneumonia (novel coronavirus
pneumonia, NCP) 1/30/2020
47 ChiCTR2000029601 2/6/2020 湖北省中医院 Hubei Provincial
Hospital of TCM 基于社区防控的“新型冠状病毒肺炎(COVID-19)”定点隔离治疗
人群中医药干预临床研究 Community based prevention and control for Chinese
medicine in the treatment of 2019-nCoV pneumonia (novel coronavirus
pneumonia, NCP) in the isolate suspected and confirmed population 2/1/
2020
48 ChiCTR2000029602 2/6/2020 湖北省中医院 Hubei Provincial
Hospital of TCM 基于社区防控的“新型冠状病毒肺炎(COVID-19)”居家/定点隔离
观察人群的临床研究 Clinical study for community based prevention and
control strategy of novel coronavirus pneumonia (COVID-19) in the isolate
suspected and confirmed population 2/1/2020
49 ChiCTR2000029603 2/6/2020 浙江大学医学院附属第一医院 The
First Affiliated Hospital of Zhejiang University School of Medicine 比较
ASC09/利托那韦复方片和洛匹那韦/利托那韦（克力芝）对于新型冠状病毒肺炎(COVID-
19)确诊病例的疗效及安全性的随机、开放、多中心的临床研究 A Randomized,
Open-Label, Multi-Centre Clinical Trial Evaluating and Comparing the Safety
and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Confirmed
Cases of 2019-nCoV Pneumonia (Novel Coronavirus Pneumonia, NCP) 2/6/2020
50 ChiCTR2000029605 2/7/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital, Tongji Medical College, Huazhong University of Science and
Technology 双黄连口服液治疗新型冠状病毒肺炎(COVID-19)有效性和安全性的随机
、开放、平行对照、多中心临床试验 A randomized, open-label, blank-
controlled, multicenter trial for Shuang-Huang-Lian oral solution in the
treatment of 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP) 2/6/
2020
51 ChiCTR2000029606 2/7/2020 浙江大学医学院附属第一医院 The
First Affiliated Hospital, College of Medicine, Zhejiang University 宫血
干细胞治疗新型冠状病毒肺炎(COVID-19)急性肺损伤（肺炎）的临床研究 Clinical
Study for Human Menstrual Blood-Derived Stem Cells in the Treatment of
Acute Novel Coronavirus Pneumonia (NCP) 1/25/2020
52 ChiCTR2000029609 2/6/2020 中山大学附属第五医院 The Fifth
Affiliated Hospital of Sun Yat-Sen University 磷酸氯喹治疗2019新型冠状病
毒肺炎(COVID-19)疗效的前瞻性、开放性、多中心临床研究 A prospective, open-
label, multiple-center study for the efficacy of chloroquine phosphate in
patients with 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP) 2/10
/2020
53 ChiCTR2000029621 2/7/2020 上海交通大学医学院附属瑞金医院
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine 盐酸阿
比多尔片治疗新型冠状病毒肺炎(COVID-19)的临床研究 Clinical study of
arbidol hydrochloride tablets in the treatment of 2019-nCoV pneumonia (novel
coronavirus pneumonia, NCP) 2/7/2020
54 ChiCTR2000029624 2/7/2020 上海市公共卫生临床中心 Shanghai
Public Health Clinical Center 中医药治疗新型冠状病毒肺炎(COVID-19)真实世
界临床观察研究 A real world study for traditional Chinese Medicine in the
treatment of 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP) 2/8/
2020
55 ChiCTR2000029625 2/7/2020 浙江大学医学院附属第一医院 The
First Affiliated Hospital of Zhejiang University School of Medicine 重症/
危重症新型冠状病毒肺炎(COVID-19)患者预警预测体系构建 Construction of
Early Warning and Prediction System for Patients with Severe / Critical 2019
-nCoV Pneumonia (Novel Coronavirus Pneumonia, NCP) 2/17/2020
56 ChiCTR2000029626 2/7/2020 浙江大学医学院附属第一医院 The
First Affiliated Hospital of Zhejiang University School of Medicine 新型
冠状病毒(COVID-19)肺炎患者外周血中免疫组库（TCR&BCR）评估和免疫治疗的研究
Immune Repertoire (TCR & BCR) Evaluation and Immunotherapy Research in
Peripheral Blood of 2019-nCoV Pneumonia (Novel Coronavirus Pneumonia, NCP)
Patients 2/17/2020
57 ChiCTR2000029628 2/7/2020 广东省中医院 Guangdong Provincial
Hospital of Chinese Medicine 新冠二号方治疗疑似新型冠状病毒感染的肺炎的临
床观察性研究 A clinical observational study for Xin-Guan-2 formula in the
treatment of suspected 2019-nCoV pneumonia (novel coronavirus pneumonia,
NCP) 2/7/2020
58 ChiCTR2000029636 2/8/2020 华中科技大学同济医学院附属协和医院
Union Hospital, Tongji Medical College, Huazhong University of Science and
Technology 雾化吸入注射用重组病毒巨噬细胞炎性蛋白（vMIP）治疗新型冠状病毒
肺炎有效性和安全性的单臂临床试验 Efficacy and safety of aerosol
inhalation of vMIP in the treatment of 2019-nCoV pneumonia (novel
coronavirus pneumonia, NCP): a single arm clinical trial 2/9/2020
59 ChiCTR2000029637 2/8/2020 广东省中医院 Guangdong Provincial
Hospital of Chinese Medicine 新冠一号方治疗新型冠状病毒肺炎(COVID-19)的观
察性研究 An observational study for Xin-Guan-1 formula in the treatment
of 2019-nCoV pneumonia (novel coronavirus pneumonia, NCP) 2/7/2020
60 ChiCTR2000029638 2/8/2020 四川大学华西医院 West China
Hospital, Sichuan University 新型重组高效复合干扰素治疗新型冠状病毒肺炎(
COVID-19)的多中心临床随机对照研究 Multicenter randomized controlled trial
for novel recombinant high-efficiency compound interferon in the treatment
of novel coronavirus pneumonia (COVID-19) 2/3/2020
61 ChiCTR2000029639 2/8/2020 中山大学附属第五医院 Department of
Psychology, the Fifth Affiliated Hospital Sun Yat-Sen University 新型冠状
病毒肺炎(COVID-19)定点医院医护患心理状况及干预：一项前瞻性、开放性的单中心临
床研究 Study for Mental health and psychological status of doctors,
nurses and patients in novel coronavirus pneumonia (COVID-19) designated
hospital and effect of interventions 2/10/2020
62 ChiCTR2000029656 2/9/2020 武汉市肺科医院 Wuhan Pulmonary
Hospital 一项评价小剂量激素治疗2019新型冠状病毒肺炎(COVID-19)住院患者的疗
效和安全性随机、开放、对照的研究 A randomized, open-label study to
evaluate the efficacy and safety of low-dose corticosteroids in hospitalized
patients with 2019-nCoV pneumonia (novel coronavirus pnuemonia, NCP) 2/
14/2020
63 ChiCTR2000029658 2/9/2020 武汉市第四人民医院/广州中医药大学第一
附属医院 The First Affiliated Hospital of Guangzhou University of TCM
高流量辅助可视软镜气管插管在危重2019新型冠状病毒肺炎(COVID-19)患者的应用
Nasal high-fow preoxygenation assisted fibre-optic bronchoscope intubation
in patients with critical 2019-nCoV pneumonia (novel coronavirus pneumonia,
NCP): a randomized clinical trial 2/10/2020
64 ChiCTR2000029695 2/10/2020 深圳第三人民医院 Shenzhen Third
People's Hospital 基于新型呼出气高通量质谱分析的新型冠状病毒肺炎(COVID-19
)早期快速检测技术研究 Early Detection of Novel Coronavirus Pneumonia
Based on a Novel High-Throughput Mass Spectrometry Analysis With Exhaled
Breath 3/1/2020
65 ChiCTR2000029728 2/10/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital, Tongji Medical College, Huazhong University of Science and
Technology 对2019新型冠状病毒性肺炎（COVID-19）流行期间同济医院工作人员
预防性用药的回顾性研究 A Retrospective Study for Preventive Medication in
Tongji Hospital during the epidemic of 2019-nCoV Pneumonia (novel
coronavirus pneumonia, NCP) 2/15/2020
66 ChiCTR2000029732 2/10/2020 四川大学华西医院 West China
Hospital, Sichuan University 维生素D缺乏对新型冠状病毒 (COVID-19) 肺炎患
者预后的影响 Impact of vitamin D deficiency on prognosis of novel
coronavirus pneumonia patients 2/10/2020
67 ChiCTR2000029734 2/10/2020 怀化市第一人民医院 The First
People's Hospital of Huaihua 新型冠状病毒肺炎(COVID-19)流行病学调查与临床
特征分析 Epidemiological investigation and clinical characteristics
analysis of novel coronavirus pneumonia (NCP) 2/8/2020
68 ChiCTR2000029735 2/10/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital, Tongji Medical College, Huazhong University of Science and
Technology 重症及死亡新型冠状病毒(COVID-19)肺炎危险因素临床分析 Risks
of Death and Severe cases in Patients with 2019 Novel Coronavirus Pneumonia
1/26/2020
69 ChiCTR2000029739 2/11/2020 广州医科大学附属第一医院 The First
Affiliated Hospital of Guangzhou Medical University 氢氧气雾化机用于改善
2019新型冠状病毒(COVID-19)肺炎患者症状的多中心、随机、平行对照临床研究 A
Multicenter, Randomized, Parallel Controlled Clinical Study of Hydrogen-
Oxygen Nebulizer to Improve the Symptoms of Patients With Novel Coronavirus
Pneumonia (COVID-19) 2/12/2020
70 ChiCTR2000029740 2/11/2020 北京大学第一医院 The First
hospital of Peking University 羟氯喹治疗新型冠状病毒(COVID-19)肺炎的临床
有效性研究 Efficacy of therapeutic effects of hydroxycholoroquine in 2019
-nCoV pneumonia (novel coronavirus pneumonia) patients 2/11/2020
71 ChiCTR2000029741 2/11/2020 中山大学附属第五医院 The Fifth
Affiliated Hospital Sun Yat-Sen University 氯喹和洛匹那韦/利托那韦片治疗
轻/普通型新型冠状病毒(CoVID-19)感染者的疗效研究：一项前瞻性、开放性、多中心
随机对照临床研究 Efficacy of Chloroquine and Lopinavir/ Ritonavir in mild
/general novel coronavirus (CoVID-19) infections: a prospective, open-label,
multicenter randomized controlled clinical study 2/12/2020
72 ChiCTR2000029742 2/11/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital, Tongji Medical College, Huazhong University of Science and
Technology 一项为期十天、随机、平行组研究，在新型冠状病毒肺炎(COVID-19)
患者中评估常规治疗基础上加用注射用七叶皂苷钠与常规治疗相比的疗效和安全性
A randomized, parallel controlled trial for the efficacy and safety of
Sodium Aescinate Injection in the treatment of patients with pneumonia (
COVID-19) 2/10/2020
73 ChiCTR2000029747 2/11/2020 安徽中医药大学第一附属医院 The
First Affiliated Hospital of Anhui University of Traditional Chinese
Medicine 基于新型冠状病毒(COVID-19)肺炎中医药干预效果评价及病程转归研究
Effect evaluation and prognosis of Chinese medicine based on Novel
Coronavirus Pneumonia (COVID-19) 2/11/2020
74 ChiCTR2000029751 2/12/2020 浙江中医药大学附属第一医院 The
First Affiliated Hospital of Zhejiang University of Traditional Chinese
Medicine 中西医防治新型冠状病毒感染肺炎(COVID-19)的临床研究 Clinical
Study for Traditional Chinese Medicine in the Prevention and Treatment of
Novel Coronavirus Pneumonia (COVID-19) 2/1/2020
75 ChiCTR2000029754 2/12/2020 四川大学华西医院 West China
Hospital, Sichuan University 新冠状病毒肺炎(COVID-19)疫情对不同疾病人群健
康的影响研究 Study for the Effect of Novel Coronavirus Pneumonia (COVID-
19) on the Health of Different People 2/10/2020
76 ChiCTR2000029755 2/12/2020 华中科技大学同济医学院附属同济医院
Institutional Review Board, Tongji Hospital, Tongji Medical College,
Huazhong University of Science and Technology 金叶败毒颗粒治疗新型冠状病
毒肺炎（COVID-19）有效性和安全性的随机、开放、平行对照临床试验 A
randomized, open, parallel-controlled trial for the efficacy and safety of
Jingyebaidu granules in treating novel coronavirus pneumonia (COVID-19) 2
/15/2020
77 ChiCTR2000029756 2/12/2020 武汉大学人民医院 Renmin Hospital
of Wuhan University 雾化吸入喜炎平注射液治疗新型冠状病毒肺炎 (COVID-19)的
临床研究 Clinical study of nebulized Xiyanping injection in the treatment
of novel coronavirus pneumonia (COVID-19) 2/15/2020
78 ChiCTR2000029757 2/12/2020 中国医学科学院输血研究所 Institute
of Blood Transfusion, Chinese Academy of Medical Sciences 采集恢复期血浆
治疗重症新型冠状病毒肺炎(COVID-19)患者的研究 Convalescent plasma for the
treatment of severe novel coronavirus pneumonia (COVID-19): a prospective
randomized controlled trial 2/14/2020
79 ChiCTR2000029758 2/12/2020 四川大学华西医院 West China
Hospital, Sichuan University 新型冠状病毒肺炎 (COVID-19)重症患者队列研究
Cohort Study of Novel Coronavirus Pneumonia (COVID-19) Critical Ill
Patients 2/3/2020
80 ChiCTR2000029759 2/12/2020 重庆医科大学附属第二医院 The
Second Affiliated Hospital of Chongqing Medical University 评价ASC09/利托
那韦复方片、洛匹那韦/利托那韦和阿比多尔对于新型冠状病毒 (COVID-19)肺炎患者的
疗效及安全性的随机、开放、多中心临床研究 A multicenter, randomized, open
label, controlled trial for the efficacy and safety of ASC09/ Ritonavir
compound tablets and Lopinavir/ Ritonavir (Kaletra) and Arbidol tablets in
the treatment of novel coronavirus pneumonia (COVID-19) 2/15/2020
81 ChiCTR2000029760 2/12/2020 重庆医科大学附属第二医院 The
Second Affiliated Hospital of Chongqing Medical University 羟氯喹治疗轻中
度新型冠状病毒(COVID-19)感染的疗效研究 A study for the efficacy of
hydroxychloroquine for mild and moderate COVID-19 infectious diseases 2/
12/2020
82 ChiCTR2000029761 2/12/2020 重庆医科大学附属第一医院 The First
Affiliated Hospital of Chongqing Medical University 硫酸羟氯喹片治疗新型
冠状病毒肺炎 (COVID-19)普通型患者的安全性和有效性的临床研究 Clinical
study on the safety and effectiveness of Hydroxychloroquine Sulfate tablets
in the treatment of patients with novel coronavirus pneumonia (COVID-19)
2/12/2020
83 ChiCTR2000029762 2/12/2020 重庆医科大学附属第一医院 The First
Affiliated Hospital of Chongqing Medical University 硫酸羟氯喹片治疗新型
冠状病毒肺炎(COVID-19)重型和危重型患者的安全性和有效性的临床研究 Clinical
study for the effect and safety of hydroxychloroquine sulfate tablets in
the treatment of patients with severe novel coronavirus pneumonia (COVID-19)
2/12/2020
84 ChiCTR2000029763 2/12/2020 中国中医科学院 China Academy of
Chinese Medical Sciences 中药治疗方舱医院新型冠状病毒肺炎 (COVID-19) 患者
前瞻性随机对照试验 The efficacy of traditional chinese medicine on Novel
Coronavirus Pneumonia (COVID-19) patients treated in square cabin hospital:
a prospective, randomized controlled trial 2/12/2020
85 ChiCTR2000029764 2/13/2020 四川大学华西医院 West China
Hospital, Sichuan University 新型冠状病毒肺炎 (COVID-19)影像学特征及机制
：一项多中心研究 Imaging Features and Mechanisms of Novel Coronavirus
Pneumonia (COVID-19): a Multicenter Study 2/16/2020
86 ChiCTR2000029765 2/13/2020 中国科学技术大学附属第一医院（安徽省
立医院） The First Affiliated Hospital of University of science and
technology of China (Anhui Provincial Hospital) 托珠单抗在新型冠状病毒肺
炎(COVID-19)中的有效性及安全性的多中心、随机对照 临床研究 A multicenter,
randomized controlled trial for the efficacy and safety of tocilizumab in
the treatment of new coronavirus pneumonia (COVID-19) 2/12/2020
87 ChiCTR2000029768 2/13/2020 武汉大学中南医院 Zhongnan Hospital
of Wuhan University 评价甘草酸二铵肠溶胶囊联合维生素C片在临床标准抗病毒
治疗基础上治疗普通型新型冠状病毒肺炎 (COVID-19)的有效性和安全性的随机、开放
、平行对照临床研究 A randomized, open, controlled trial for diammonium
glycyrrhizinate enteric-coated capsules combined with vitamin C tablets in
the treatment of common novel coronavirus pneumonia (COVID-19) in the basic
of clinical standard antiviral treatment to evaluate the safety and
efficiency 2/11/2020
88 ChiCTR2000029769 2/13/2020 浙江省台州医院 Taizhou Hospital of
Zhejiang Province 八宝丹用于新型冠状病毒肺炎(COVID-19)重症患者辅助治疗
Babaodan Capsule used for the adjuvant treatment of Severe novel
coronavirus pneumonia (COVID-19) 2/15/2020
89 ChiCTR2000029770 2/13/2020 华中科技大学同济医学院附属协和医院
Union Hospital, Tongji Medical College, Huazhong University of Science and
Technology 新型冠状病毒肺炎(COVID-19)的流行病学及诊治研究 Study for
epidemiology, diagnosis and treatment of novel coronavirus pneumonia (COVID-
19) 2/13/2020
90 ChiCTR2000029776 2/13/2020 温州医科大学附属第一医院 The First
Affiliated of Wenzhou Medical University 聚肌胞注射液治疗新型冠状病毒肺
炎 (COVID-19)有效性和安全性的随机、开放、平行对照、多中心临床试验 A
randomized, open-label, blank-controlled, multicenter trial for Polyinosinic
-Polycytidylic Acid Injection in the treatment of novel coronavirus
pneumonia (COVID-19) 2/11/2020
91 ChiCTR2000029777 2/13/2020 黄石市中医医院 Huangshi Hospital
of Traditional Chinese Medicine 基于“截断扭转”策略中西医结合治疗重症新
型冠状病毒肺炎 (COVID-19)的多中心、随机、对照研究 A multicenter,
randomized, controlled trial for integrated chinese and western medicine in
the treatment of novel coronavirus pneumonia (COVID-19) based on the '
Truncated Torsion' strategy 2/5/2020
92 ChiCTR2000029778 2/13/2020 上海中医药大学附属曙光医院
Shuguang Hospital Affiliated to Shanghai University of TCM. 中西医协同防
治新型冠状病毒肺炎(COVID-19)的临床研究 Clinical Study for Traditional
Chinese Medicine Combined With Western Medicine in Treatment of Novel
Coronavirus Pneumonia (COVID-19) 2/14/2020
93 ChiCTR2000029779 2/13/2020 无锡市人民医院 Wuxi People's
Hospital 基于医学影像的新型冠状病毒肺炎 (COVID-19)诊治关键问题研究
Study for the key issues of the diagnosis and treatment of novel coronavirus
pneumonia (COVID-19) based on the medical imaging 2/14/2020
94 ChiCTR2000029780 2/13/2020 华中科技大学同济医学院附属协和医院
Union Hospital affiliated to Tongji Medical College of Huazhong University
of Science and Technology 评价参芪扶正注射液治疗新型冠状病毒肺炎 (COVID-
19)有效性和安全性的多中心、随机、开放、对照研究 A multicenter, randomized
, open, controlled trial for the efficacy and safety of Shen-Qi Fu-Zheng
injection in the treatment of novel coronavirus pneumonia (COVID-19) 2/14
/2020
95 ChiCTR2000029781 2/13/2020 华中科技大学同济医学院附属协和医院
Union Hospital affiliated to Tongji Medical College of Huazhong University
of Science and Technology 评价抗病毒颗粒治疗新型冠状病毒肺炎 (COVID-19)有
效性和安全性的多中心、随机、开放、对照研究 A multicenter, randomized,
open and controlled trial for the efficacy and safety of Kang-Bing-Du
granules in the treatment of novel coronavirus pneumonia (COVID-19) 2/14/
2020
96 ChiCTR2000029782 2/13/2020 浙江省人民医院 Zhejiang Provincial
People's Hospital 新型冠状病毒(COVID-19)流行期间浙江省某综合性三甲医院肿
瘤放射治疗医护人员心理状态改变的临床研究 Clinical study for the changes
in mental state of medical staff in the department of radiotherapy in a
comprehensive tertiary hospital in Zhejiang Province during the epidemic of
novel coronavirus infection (COVID-19) 1/30/2020
97 ChiCTR2000029788 2/13/2020 北京中医药大学附属东直门医院
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine
中医合作治疗模式对新型冠状病毒肺炎（COVID-19）患者的临床疗效及免疫功能的影响
Traditional Chinese medicine cooperative therapy for patients with novel
coronavirus pneumonia (COVID-19): a randomized controlled trial 3/1/2020
98 ChiCTR2000029789 2/13/2020 河南中医药大学 He'nan University
of Chinese Medicine 中医辨证治疗对新型冠状病毒肺炎 (COVID-19)患者出院后生
存质量影响的随机对照试验 Randomized controlled trial for TCM syndrome
differentiation treatment impacting quality of life of post-discharge
patients with novel coronavirus pneumonia (COVID-19) 2/15/2020
99 ChiCTR2000029790 2/13/2020 上海市肺科医院 Shanghai Pulmonary
Hospital 中西医结合治疗新型冠状病毒肺炎 (COVID-19) 的临床研究
Clinical study for the integration of traditional Chinese and western
medicine in the treatment of novel coronavirus pneumonia (COVID-19) 2/17/
2020
100 ChiCTR2000029803 2/14/2020 武汉大学人民医院 Renmin Hospital
of Wuhan University 评价羟氯喹对医务人员新型冠状病毒 (COVID-19) 暴露后预
防效果的前瞻性、随机、开放性、平行对照临床研究 A prospective, randomized,
open-label, parallel controlled trial for the preventive effect of
hydroxychloroquine on medical personnel after exposure to COVID-19 2/15/
2020
101 ChiCTR2000029804 2/14/2020 武汉市金银潭医院（武汉市传染病医院）
Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital) 体外膜
肺氧合技术救治2019新型冠状病毒肺炎(COVID-19)极危重呼吸衰竭患者的临床应用研究
Clinical Application of ECMO in the Treatment of Patients with Very
Serious Respiratory Failure due to novel Coronavirus Pneumonia (COVID-19)
2/12/2020
102 ChiCTR2000029805 2/14/2020 武汉市金银潭医院（武汉市传染病医院）
Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital) 2019新
型冠状病毒 (COVID-19) 重症肺炎的临床特点分析 Analysis of clinical
characteristics of severe novel coronavirus pneumonia (COVID-19) 2/12/
2020
103 ChiCTR2000029806 2/14/2020 武汉市金银潭医院（武汉市传染病医院）
Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital) 2019新
型冠状病毒(COVID-19)感染重症肺炎的免疫调节治疗 Immunomodulatory Therapy
for Severe Novel Coronavirus Pneumonia (COVID-19) 2/12/2020
104 ChiCTR2000029810 2/14/2020 深圳市第二人民医院 Shenzhen
Second People's Hospital 基于CRISPR-Cas蛋白的高灵敏度新型冠状病毒肺炎（
COVID-19）核酸检测技术的临床研究 Clinical study of a novel high
sensitivity nucleic acid assay for novel coronavirus pneumonia (COVID-19)
based on CRISPR-cas protein 2/16/2020
105 ChiCTR2000029811 2/14/2020 广州瑞铂茵健康管理咨询有限公司
Guangzhou reborn health management consultation co., LTD 抗衰活性冻干粉颗
粒用于治疗新型冠状病毒肺炎(COVID-19)的临床研究 Clinical Study for Anti-
aging Active Freeze-dried Powder Granules in the Treatment of Acute Novel
Coronavirus Pneumonia (COVID-19) 2/20/2020
106 ChiCTR2000029812 2/14/2020 广州瑞铂茵健康管理咨询有限公司
Guangzhou reborn health management consultation co., LTD 脐血单个核细胞用
于治疗新型冠状病毒肺炎(COVID-19)的临床研究 Clinical Study for Umbilical
Cord Blood Mononuclear Cells in the Treatment of Acute Novel Coronavirus
Pneumonia (COVID-19) 2/20/2020
107 ChiCTR2000029813 2/14/2020 上海市公共卫生临床中心 Shanghai
Public Health Clinical Center 痰热清胶囊治疗新型冠状病毒肺炎 (COVID-19)
临床试验 Clinical Trial for Tanreqing Capsules in the Treatment of Novel
Coronavirus Pneumonia (COVID-19) 2/12/2020
108 ChiCTR2000029814 2/14/2020 复旦大学附属儿科医院 Children's
Hospital of Fudan University 中西医结合治疗儿童新型冠状病毒肺炎(COVID-19)
的临床研究 Clinical Trial for Integrated Chinese and Western Medicine in
the Treatment of Children with Novel Coronavirus Pneumonia (COVID-19) 2/
14/2020
109 ChiCTR2000029815 2/14/2020 广东省中医院 Guangdong Provincial
Hospital of Chinese Medicine 新型冠状病毒肺炎(COVID-19)流行期间全国各地
区一线医护人员心理调查研究 Psychological survey of frontline medical
staff in various regions of China during the epidemic of novel coronavirus
pneumonia (COVID-19) 2/1/2020
110 ChiCTR2000029816 2/14/2020 广州瑞铂茵健康管理咨询有限公司
Guangzhou reborn health management consultation co., LTD 脐血间充质干细胞
用于治疗新型冠状病毒肺炎(COVID-19)的临床研究 Clinical Study for Cord
Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus
Pneumonia (COVID-19) 2/20/2020
111 ChiCTR2000029817 2/14/2020 广州瑞铂茵健康管理咨询有限公司
Guangzhou reborn health management consultation co., LTD 脐血NK细胞联合脐
血间充质干细胞用于治疗新型冠状病毒肺炎(COVID-19)的临床研究 Clinical Study
of Cord Blood NK Cells Combined with Cord Blood Mesenchymal Stem Cells in
the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19) 2/20/2020
112 ChiCTR2000029818 2/14/2020 广州瑞铂茵健康管理咨询有限公司
Guangzhou reborn health management consultation co., LTD 脐血浆用于治疗新
型冠状病毒肺炎(COVID-19)的临床研究 Clinical Study for Umbilical Cord
Blood Plasma in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19
) 2/20/2020
113 ChiCTR2000029819 2/14/2020 浙江大学医学院附属邵逸夫医院 Sir
Run Run Show Hospital, School of Medicine, Zhejiang University 八宝丹用于
新型冠状病毒肺炎(COVID-19)重症患者辅助治疗 Ba-Bao-Dan in the adjuvant
therapy of novel coronavirus pneumonia (COVID-19) patients 2/11/2020
114 ChiCTR2000029820 2/14/2020 武汉亚心总医院 Wuhan Asia General
Hospital 新型冠状病毒肺炎(COVID-19)预后的COX回归分析 A cox regression
analysis of prognosis of novel coronavirus pneumonia (COVID-19) 2/1/2020
115 ChiCTR2000029821 2/14/2020 德阳市中西医结合医院 Deyang
integrative medicine hospital 基于德尔菲法初步构建德阳地区运用中医药技术
预防“新型冠状病毒感染肺炎(COVID-19) ”推荐方案及其临床应用评价 Based on
Delphi Method to Preliminarily Construct a Recommended Protocol for the
Prevention of Novel Coronavirus Pneumonia (COVID-19) in Deyang Area by Using
Chinese Medicine Technology and its Clinical Application Evaluation 2/14
/2020
116 ChiCTR2000029822 2/14/2020 南京市第二医院 Nanjing Second
Hospital 金银花汤剂在新型冠状病毒(COVID-19)感染的患者中的治疗作用的随机对
照研究 A randomized controlled trial for honeysuckle decoction in the
treatment of patients with novel coronavirus (COVID-19) infection 2/7/
2020
117 ChiCTR2000029826 2/14/2020 荆州市中心医院 Jingzhou Central
Hospital 磷酸氯喹片联合标准疗法对比标准疗法治疗重型/危重型 2019 冠状病毒
病（COVID-19）的随机、双盲、平行对照研究 A randomized, double-blind,
parallel, controlled trial for comparison of phosphoric chloroquine combined
with standard therapy and standard therapy in serious/critically ill
patients with novel coronavirus pneumonia (COVID-19) 2/17/2020
118 ChiCTR2000029829 2/15/2020 重庆三峡中心医院 Three Gorges
Central Hospital 心型酯肪酸结合蛋白对新型冠状病毒肺炎(COVID-19)预后的临床
观察 Medical records based study for Heart-type fatty acid-binding
protein on prognosis of novel coronavirus pneumonia (COVID-19) 2/15/2020
119 ChiCTR2000029830 2/15/2020 中山大学附属第五医院 The Fifth
Affiliated Hospital of Sun Yat-Sen University 新型冠状病毒肺炎(COVID-19)
爆发时期综合医院肿瘤住院患者的心理状况、社会支持与照护需求研究 A study
for the psychological status, social support, and care needs of tumor
patients admitted to a general hospital during the novel coronavirus
pneumonia (COVID-19) outbreak 2/14/2020
120 ChiCTR2000029837 2/15/2020 荆州市中心医院 Jingzhou Central
Hospital 磷酸氯喹片联合标准疗法对比标准疗法治疗轻型/普通型 2019 冠状病毒
肺炎（COVID-19）的随机、双盲、平行对照研究 A randomized, double-blind,
parallel, controlled trial for comparison of phosphoric chloroquine combined
with standard therapy and standard therapy in mild/common patients with
novel coronavirus pneumonia (COVID-19) 2/17/2020
121 ChiCTR2000029839 2/15/2020 宁波市第一医院 Ningbo First
Hospital 新型冠状病毒肺炎 (COVID-19) 临床特征、治疗措施与临床结局观察性研
究 An observational study on the clinical characteristics, treatment and
outcome of novel coronavirus pneumonia (COVID-19) 2/10/2020
122 ChiCTR2000029849 2/15/2020 郑州大学第一附属医院 The First
Affiliated Hospital of Zhengzhou University 调节肠道菌群治疗在重型新型冠
状病毒肺炎(COVID-19)中的应用研究 Application of Regulating Intestinal
Flora in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19) 2
/1/2020
123 ChiCTR2000029850 2/15/2020 浙江大学医学院附属第一医院感染病科,
传染病诊治国家重点实验室, 国家感染性疾病临床医学研究中心 The First
Affiliated Hospital of Zhejiang University, State Key Laboratory for
Diagnosis and Treatment of Infectious Diseases, National Clinical Research
Center for Infectious Disease 新型冠状病毒肺炎 (COVID-19) 重症患者免疫血
清治疗的临床研究 Study for convalescent plasma treatment for severe
patients with novel coronavirus pneumonia (COVID-19) 2/15/2020
124 ChiCTR2000029851 2/15/2020 复旦大学附属中山医院 Zhongshan
Hospital, Fudan University 硫辛酸注射液在新型冠状病毒肺炎(COVID-19)重型及
危重型患者中的有效性及安全性的多中心、随机对照临床研究 A multicenter,
randomized controlled trial for the efficacy and safety of Alpha lipoic acid
(iv) in the treatment of patients of severe novel coronavirus pneumonia (
COVID-19) 2/23/2020
125 ChiCTR2000029853 2/15/2020 光山县人民医院 People's Hospital
of Guangshan County 阿兹夫定片治疗新型冠状病毒感染肺炎(COVID-19)的随机、
开放、对照临床试验 A randomized, open-label, controlled clinical trial
for azvudine in the treatment of novel coronavirus pneumonia (COVID-19) 2
/16/2020
126 ChiCTR2000029855 2/15/2020 浙江大学医学院附属第一医院 The
First Affiliated Hospital of Medical College of Zhejiang University 中医
药治疗新型冠状病毒肺炎(COVID-19)的随机、开放、对照临床试验 A randomized,
open and controlled clinical trial for traditional Chinese medicine in the
treatment of novel coronavirus pneumonia (COVID-19) 2/15/2020
127 ChiCTR2000029865 2/15/2020 华中科技大学同济医学院附属协和医院
Union Hospital Affiliated to Tongji Medical College of Huazhong University
of Science and Technology 心血管病患者感染新型冠状病毒肺炎 (COVID-19) 临
床特点及其转归的描述性研究 Descriptive study for the clinical
characteristics and outcomes of novel coronavirus pneumonia (COVID-19) in
cardiovascular patients 2/20/2020
128 ChiCTR2000029866 2/15/2020 台州市恩泽医疗中心（集团）恩泽医院/
浙江省台州医院 Enze Hospital of Taizhou Enze Medical Center (Group)/
Taizhou Hospital of Zhejiang Province 基于多组学重症新型冠状病毒肺炎(
COVID-19)患者早期预警预测研究 Early warning prediction of patients with
severe novel coronavirus pneumonia (COVID-19) based on multiomics 2/17/
2020
129 ChiCTR2000029867 2/15/2020 首都医科大学附属北京佑安医院
Beijing You'an Hospital, Capital Medical University 评价口服可利霉素对新
冠病毒肺炎(COVID-19)患者疗效和安全性 的随机、开放、阳性药对照、多中心临床研
究 The efficacy and safety of carrimycin treatment in patients with novel
coronavirus infectious disease (COVID-19): a multicenter, randomized, open-
label controlled trial 2/15/2020
130 ChiCTR2000029868 2/15/2020 上海交通大学医学院附属瑞金医院
Ruijin Hospital, Shanghai Jiaotong University School of Medicine 羟氯喹治
疗轻中度新型冠状病毒肺炎 (COVID-19)——全国多中心研究 Hydroxychloroquine
treating novel coronavirus pneumonia (COVID-19): a multicenter, randomized
controlled trial 2/10/2020
131 ChiCTR2000029869 2/15/2020 黄石市中医医院 Huangshi Hospital
of Traditional Chinese Medicine 基于“表里双解-截断扭转”策略中西医结合
治疗普通型新冠肺炎(COVID-19)的随机对照研究 A multicenter, randomized,
controlled trial for integrated Chinese and western medicine in the
treatment of ordinary novel coronavirus pneumonia (COVID-19) based on the '
Internal and External Relieving -Truncated Torsion' strategy 2/10/2020
132 ChiCTR2000029870 2/15/2020 江苏省血吸虫病防治研究所 Jiangsu
Institute of Parasitic Diseases 新型冠状病毒肺炎(COVID-19)IgM/IgG 快速诊
断试剂盒效果评估 Evaluation of Rapid Diagnostic Kit (IgM/IgG) for Novel
Coronavirus Pneumonia (COVID-19) 2/15/2020
133 ChiCTR2000029883 2/16/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital, Tongji Medical College, Huazhong University of Science
and Technology 鼻咽和口咽标本经PCR 检测 SARS-CoV-2 敏感性的比较研究 A
comparative study on the sensitivity of nasopharyngeal and oropharyngeal
swabbing for the detection of influenza virus by real-time PCR 2/17/2020
134 ChiCTR2000029895 2/16/2020 广州市第八人民医院 Guangzhou
Eighth People's Hospital GD31治疗新型冠状病毒肺炎(COVID-19) 有效性和安全
性单臂临床试验 Single arm study for the efficacy and safety of GD31 in
patients with novel coronavirus pneumonia (COVID-19) 2/16/2020
135 ChiCTR2000029896 2/16/2020 长春中医药大学附属医院 Affiliated
Hospital of Changchun University of traditional Chinese Medicine 中医药
治疗新型冠状病毒肺炎(COVID-19)的效果评价 Evaluate the effectiveness of
Traditional Chinese medicine in the treatment of novel coronavirus pneumonia
(COVID-19) 1/31/2020
136 ChiCTR2000029898 2/16/2020 北京大学第三医院 Peking
University Third Hospital 磷酸氯喹治疗重型及危重型新型冠状病毒肺炎（COVID
-19）患者的 有效性和安全性研究：一项前瞻性、多中心、 开放、随机对照临床研究
A Randomized, Open-label, Parallel, Controlled Trial for Evaluation of
the Efficacy and Safety of Chloroquine Phosphate in the treatment of Severe
Patients with Novel Coronavirus Pneumonia (COVID-19) 2/17/2020
137 ChiCTR2000029899 2/16/2020 北京大学第三医院 Peking
University Third Hospital 磷酸氯喹/硫酸羟氯喹治疗轻型及普通型新型冠状病毒
肺炎（COVID-19）患者的有效性和安全性研究：一项前瞻性、多中心、开放、随机对照
临床研究 A Prospective, Multicenter, Open, Randomized Controlled Trial
for Evaluation of the Efficacy and Safety of Chloroquine Phosphate and
Hydroxychloroquine Sulfate in the treatment of Patients With Mild and
Common type novel coronavirus pneumonia (COVID-19) 2/17/2020
138 ChiCTR2000029900 2/16/2020 武汉大学人民医院 Renmin Hospital
of Wuhan University 医务工作者新型冠状病毒肺炎(COVID-19)易感因素调查与院
内防控策略研究 Research for Risks Associated with Novel Coronavirus
Pneumonia (COVID-19) in the Hospital Workers and Nosocomial Prevention and
Control Strategy 2/17/2020
139 ChiCTR2000029905 2/16/2020 武汉大学中南医院 Zhongnan
Hospital of Wuhan University 新型冠状病毒(COVID-19)与流感病毒共感染临床研
究 A medical records based study of novel coronavirus pneumonia (COVID-19
) and influenza virus co-infection 2/10/2020
140 ChiCTR2000029907 2/16/2020 四川大学华西医院 West China
Hospital, Sichuan University 新型冠状病毒(COVID-19)感染临床风险预警模型的
构建与评价 Study for construction and assessment of early warning score
of the clinical risk of novel coronavirus (COVID-19) infected patients 2/
16/2020
141 ChiCTR2000029935 2/17/2020 中国科学院大学宁波华美医院 HwaMei
Hospital, University of Chinese Academy of Sciences 磷酸氯喹片治疗新型冠
状病毒肺炎(COVID-19)的单臂临床试验研究 A Single-arm Clinical Trial for
Chloroquine Phosphate in the treatment of Novel Coronavirus Pneumonia 2019 (
COVID-19) 2/6/2020
142 ChiCTR2000029939 2/17/2020 中国科学院大学宁波华美医院 HwaMei
Hospital, University of Chinese Academy of Sciences 磷酸氯喹片治疗新型冠
状病毒肺炎(COVID-19)的单盲、随机、对照临床试验研究 A Single-blind,
Randomized, Controlled Clinical Trial for Chloroquine Phosphate in the
Treatment of Novel Coronavirus Pneumonia 2019 (COVID-19) 2/10/2020
143 ChiCTR2000029941 2/17/2020 上海中医药大学附属龙华医院
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese
Medicine 中医药分期辨治新型冠状病毒肺炎（COVID-19）的随机对照试验 A
randomized controlled trial for Traditional Chinese Medicine in the
treatment for Novel Coronavirus Pneumonia (COVID-19) 3/1/2020
144 ChiCTR2000029947 2/17/2020 上海中医药大学附属龙华医院
Longhua Hospital Affiliated to Shanghai University of Traditional Chinese
Medicine 清疫4号治疗新型冠状病毒肺炎(COVID-19)恢复期的随机对照临床研究
A Randomized Controlled Trial for Qingyi No. 4 Compound in the treatment
of Convalescence Patients of Novel Coronavirus Pneumonia (COVID-19) 3/1/
2020
145 ChiCTR2000029949 2/17/2020 武汉大学中南医院急救中心
Emergency Department of Zhongnan hospital of Wuhan University 人工肺(体外
膜氧合)在新型冠状病毒感染(COVID-19)的重症肺炎患者中的应用效果：基于病历记录
的分析 A Medical Records Based Study for the Effectiveness of
Extracorporeal Membrane Oxygenation in Patients with Severe Novel
Coronavirus Pneumonia (COVID-19) 2/16/2020
146 ChiCTR2000029952 2/17/2020 重庆三峡中心医院 Chongqing Three
Gorges Central Hospital 重庆市新型冠状病毒肺炎(COVID-19)的流行病学和临床
特征：基于病历记录的分析及研究 Medical records based study for
epidemiological and clinical characteristics of 2019 novel coronavirus
pneumonia (COVID-19) in Chongqing 2/16/2020
147 ChiCTR2000029953 2/17/2020 武汉大学中南医院急救中心
Emergency Department of Zhongnan hospital of Wuhan University 新型冠状病
毒肺炎(COVID-19)预后预测模型构建与分析研究 Construction and Analysis of
Prognostic Predictive Model of Novel Coronavirus Pneumonia (COVID-19) 2/
16/2020
148 ChiCTR2000029954 2/17/2020 湖北省中医院 Hubei Hospital of
Traditional Chinese Medicine 金银花口服液治疗新型冠状病毒感染(COVID-19)的
肺炎的有效性和安全性的多中心、随机、对照、开放式临床研究 Efficacy and
safety of honeysuckle oral liquid in the treatment of novel coronavirus
pneumonia (COVID-19): a multicenter, randomized, controlled, open clinical
trial 4/30/2020
149 ChiCTR2000029955 2/17/2020 四川大学华西第二医院 West China
Second University Hospital, Sichuan University 新型冠状病毒(COVID-19)心肌
损伤的多模态MRI影像评价 Evaluation of myocardial injury of novel
coronavirus pneumonia (COVID-19) assessed by multimodal MRI imaging 3/1/
2020
150 ChiCTR2000029956 2/17/2020 成都中医药大学附属医院 Hospital
of Chengdu University of Traditional Chinese Medicine 中医药促进新型冠状
病毒(COVID-19)感染后康复方案 Chinese Medicine Promotes Rehabilitation
Recommendations after 2019 Novel Coronavirus Infection (COVID-19) 2/18/
2020
151 ChiCTR2000029957 2/17/2020 西安交通大学第二附属医院 The
Second Affiliated Hospital of Xi'an Jiaotong University 大剂量维生素C治疗
重型及危重型新型冠状病毒肺炎 (COVID-19) 的观察性研究 An observational
study of high-dose Vitamin C in the treatment of severe and critical
patients with novel coronavirus pneumonia (COVID-19) 2/18/2020
152 ChiCTR2000029958 2/17/2020 武汉大学中南医院 Zhongnan
Hospital of Wuhan University 围术期新型冠状病毒肺炎(COVID-19)手术病人麻醉
临床特征及麻醉科医护感染、心理健康情况评估 A medical records based study
for the clinical characteristics of anesthesia novel coronavirus pneumonia (
COVID-19) patients during perioperative period and assessment of infection
and mental health of Anesthesiology Department 2/17/2020
153 ChiCTR2000029959 2/17/2020 四川大学华西第二医院 West China
Second University Hospital, Sichuan University 围产新生儿严重急性呼吸综合
征新型冠状病毒（COVID-19）感染临床观察研究 Clinical observation and
research of Severe acute respiratory syndrome coronavirus 2(COVID-19)
infection in perinatal newborns 1/25/2020
154 ChiCTR2000029960 2/17/2020 湖南中医药大学第一附属医院 The
First Affiliated Hospital of Hu'nan University of traditional Chinese
Medicine 湖南省新型冠状病毒肺炎(COVID-19)中西医结合诊疗的临床对照研究
Comparative study for integrate Chinese and conventional medicine the the
treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province 2/
28/2020
155 ChiCTR2000029972 2/17/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital, Tongji Medical College, Huazhong University of Science
and Technology 超短波对2019新型冠状病毒肺炎(COVID-19)的疗效研究 A
randomized controlled trial for the Efficacy of Ultra Short Wave
Electrotherapy in the treatment of Novel Coronavirus Pneumonia (COVID-19)
2/17/2020
156 ChiCTR2000029974 2/18/2020 山东大学齐鲁医院 Qilu Hospital of
Shandong University 一项前瞻性评价微生态制剂治疗2019新型冠状病毒肺炎(
COVID-19)患者的疗效和安全性的多中心、开放、随机、平行对照试验 A
prospective, multicenter, open-label, randomized, parallel-controlled trial
for probiotics to evaluate efficacy and safety in patients infected with
2019 novel coronavirus pneumonia (COVID-19) 2/9/2020
157 ChiCTR2000029975 2/18/2020 吉林大学第一医院 The First
Hospital of Jilin University 磷酸氯喹雾化吸入治疗新冠病毒感染肺炎(COVID-
19)的单臂探索性研究 Single arm study for exploration of chloroquine
phosphate aerosol inhalation in the treatment of novel coronavirus pneumonia
(COVID-19) 2/24/2020
158 ChiCTR2000029976 2/18/2020 上海中医药大学 Shanghai
University of Traditional Chinese Medicine 健身气功养肺方对轻症新冠肺炎(
COVID-19)患者功能恢复和生活质量的影响 The effect of Gymnastic Qigong
Yangfeifang on functional recovery and quality of life in patients with mild
novel coronavirus pneumonia (COVID-19) 2/19/2020
159 ChiCTR2000029978 2/18/2020 上海中医药大学附属岳阳中西医结合医院
推拿研究所 Tuina Institute, Yueyang Hospital of Integrated Traditional
Chinese and Western Medicine, Shanghai University of Traditional Chinese
Medicine 中医传统导引功法防控新型冠状病毒肺炎(COVID-19)的随机对照试验
A randomized controlled trial for the efficacy of Dao-Yin in the prevention
and controlling novel coronavirus pneumonia (COVID-19) 2/21/2020
160 ChiCTR2000029981 2/18/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital, Tongji Medical College, Huazhong University of Science
and Technology 新型冠状病毒肺炎(COVID-19)疫情背景下女性阴道分泌物核酸检测
的观察性研究 Study for nucleic acid detection of novel coronavirus
pneumonia (COVID-2019) in female vaginal secretions 2/18/2020
161 ChiCTR2000029982 2/18/2020 华中科技大学同济医学院附属协和医院
Union Hospital, Tongji Medical College, Huazhong University of Science and
Technology 运用多组学方法对新冠状病毒性肺炎(COVID-19)的诊断与治疗进行研
究 Study for using multiomics in the diagnosis and treatment of novel
coronavirus pneumonia (COVID-19) 2/18/2020
162 ChiCTR2000029984 2/18/2020 广州瑞铂茵健康管理咨询有限公司
Guangzhou reborn health management consultation co., LTD 人类胎盘生物制剂
提高免疫功能防御对抗新型冠状病毒肺炎(COVID-19)的疗效研究 Study on the
effect of human placenta biological preparation on the defense of immune
function against novel coronavirus pneumonia (COVID-19) 3/1/2020
163 ChiCTR2000029985 2/18/2020 四川省医学科学院·四川省人民医院
Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital
新型冠状病毒肺炎(COVID-19)防疫期间护理人员心理健康现状及影响因素研究
Study for mental health status and influencing factors of nurses during
epidemic prevention of novel coronavirus pneumonia (COVID-19) 2/10/2020
164 ChiCTR2000029988 2/18/2020 武汉大学中南医院 Zhongnan
Hospital of Wuhan University 磷酸氯喹用于治疗重症新型冠状病毒肺炎 (COVID-
19)的临床研究 Clinical Study of Chloroquine Phosphate in the Treatment of
Severe Novel Coronavirus Pneumonia (COVID-19) 2/13/2020
165 ChiCTR2000029989 2/18/2020 中国人民解放军总医院 Chinese PLA
General Hospital 重组人干扰素α1b滴眼液治疗老年新型冠状病毒感染肺炎(COVID
-19)的随机、双盲、对照的多中心临床研究 A randomized controlled Trial for
therapeutic efficacy of Recombinant Human Interferon alpha 1b Eye Drops in
the treatment of elderly with novel coronavirus pneumonia (COVID-19) 2/20
/2020
166 ChiCTR2000029990 2/18/2020 中国医学科学院基础医学研究所
institute of basic medicine, Chinese Academy of medical sciences 人间充质
干细胞治疗 新型冠状病毒感染肺炎的临床研究 Clinical trials of mesenchymal
stem cells for the treatment of pneumonitis caused by novel coronavirus
pneumonia (COVID-19) 1/30/2020
167 ChiCTR2000029991 2/18/2020 南昌大学第一附属医院 The First
Affiliated Hospital of Nanchang University 咳速停糖浆、咳清胶囊治疗轻型和
普通型新型冠状病毒肺炎 (COVID-19) 有效性和安全性的随机、开放、平行对照、多中
心临床试验 A randomized, open-label, controlled trial for the safety and
efficiency of Kesuting syrup and Keqing capsule in the treatment of mild and
moderate novel coronavirus pneumonia (COVID-19) 2/21/2020
168 ChiCTR2000029992 2/18/2020 厦门大学附属中山医院 Zhongshan
Hospital Affiliated to Xiamen University 磷酸氯喹、硫酸羟氯喹在新型冠状病
毒重症肺炎 (COVID-19) 患者的前瞻性开放性随机对照试验 A prospective,
randomized, open label, controlled trial for chloroquine and
hydroxychloroquine in patients with severe novel coronavirus pneumonia (
COVID-19) 2/17/2020
169 ChiCTR2000029993 2/19/2020 广州医科大学附属第一医院 The
First Affiliated Hospital of Guangzhou Medical University 中西医结合治疗
非危重型新型冠状病毒 (COVID-19) 感染的临床研究：预试验 A pilot study for
Integrated Chinese and Western Medicine in the treatment of non-critical
novel coronavirus pneumonia (COVID-19) 2/20/2020
170 ChiCTR2000029994 2/19/2020 黄石市中医医院/上海中医药大学康复医
学院 Huangshi Hospital of TCM/Faculty of Rehabilitation Medicine,
Shanghai University of Chinese Medicine 六字诀结合宽胸理气手法对新型冠状
病毒肺炎(COVID-19)重症患者肺功能及生存质量的临床随机对照研究 Liu-Zi-Jue
Qigong and Acupressure Therapy for Pulmonary Function and Quality of Life in
Patient with Severe novel coronavirus pneumonia (COVID-19): A Randomized
Controlled Trial 2/19/2020
171 ChiCTR2000029995 2/19/2020 上海交通大学附属上海市第一人民医院
Shanghai General hospital of Shanghai Jiaotong University 新型冠状病毒
(COVID-19)感染形式下不同人群焦虑心理研究 Study on anxiety of different
populations under novel coronavirus (COVID-19) infection 2/20/2020
172 ChiCTR2000029996 2/19/2020 首都医科大学附属北京朝阳医院
Beijing Chaoyang Hospital, Capital Medical University 一项评价法匹拉韦片
在普通型新型冠状病毒肺炎 (COVID-19) 患者中的有效性、安全性的随机、开放、剂量
探索的临床研究 2/20/2020
173 ChiCTR2000029999 2/19/2020 上海市第十人民医院 Shanghai 10th
People's Hospital, Tongji University 益生菌制剂调控新冠肺炎(COVID-19)肠道
功能及菌群结构的临床研究 A clinical study for probiotics in the
regulation of intestinal function and microflora structure of novel
coronavirus pneumonia (COVID-19) 2/20/2020
174 ChiCTR2000030000 2/19/2020 南昌市第九医院 Nanchang Ninth
Hospital 评价戈诺卫联合利托那韦以及中西医结合方案治疗新型冠状病毒感染(
COVID-19)患者的疗效及安全性的开放、对照临床研究 An open, controlled
clinical trial for evaluation of ganovo combined with ritonavir and
integrated traditional Chinese and Western medicine in the treatment of
novel coronavirus infection (COVID-19) 2/16/2020
175 ChiCTR2000030001 2/19/2020 黑龙江省医院 Heilongjiang
Province hospital 特力阿扎维林治疗2019新型冠状病毒肺炎(COVID-19)患者有效
性和安全性的多中心、随机、双盲、安慰剂对照临床研究 The efficacy and
safety of Triazavirin for 2019 novel coronary pneumonia (COVID-19): a
multicenter, randomized, double blinded, placebo-controlled trial 2/15/
2020
176 ChiCTR2000030002 2/19/2020 中国科学技术大学附属第一医院（安徽省
立医院） The First Affiliated Hospital of University of science and
technology of China (Anhui Provincial Hospital) 新型NLRP3炎症小体抑制剂
曲尼司特用于新型冠状病毒肺炎(COVID-19)治疗的临床研究 Clinical study of
novel NLRP Inflammasome inhibitor (Tranilast) in the treatment of novel
coronavirus pneumonia (COVID-19) 2/15/2020
177 ChiCTR2000030003 2/19/2020 成都中医药大学附属医院 Affiliated
Hospital of Chengdu University of Traditional Chinese Medicine 新型冠状
病毒肺炎(COVID-19)中西医结合治疗优化方案 Optimization Protocal of
Integrated Traditional Chinese and Western Medicine in the Treatment for
Novel Coronavirus Pneumonia (COVID-19) 2/19/2020
178 ChiCTR2000030004 2/19/2020 四川大学华西医院 West China
Hospital, Sichuan University 新型冠状病毒肺炎(COVID-19)疫情对大学生心理健
康的影响 Effect of Novel Coronavirus Pneumonia (COVID-19) on the Mental
Health of College Students 2/20/2020
179 ChiCTR2000030005 2/19/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital, Tongji Medical College, Huazhong University of Science
and Technology 新型冠状病毒肺炎(COVID-19)晨起痰液标本和咽拭子标本中的核酸
检测准确性分析—一个的前瞻性诊断性试验 Nucleic acid analysis of novel
coronavirus (COVID-19) in morning salivary samples and pharyngeal swabs-a
prospectively diagnostic test 2/21/2020
180 ChiCTR2000030006 2/19/2020 华中科技大学同济医学院附属协和医院
Union Hospital, Tongji Medical College, Huazhong University of Science and
Technology 三氧大自血疗法对新型冠状病毒肺炎 (COVID-19)的治疗作用 A
randomized controlled trial for the efficacy of ozonated autohemotherapy in
the treatment of Novel Coronavirus Pneumonia (COVID-19) 2/19/2020
181 ChiCTR2000030007 2/19/2020 广州医科大学附属第一医院
Multicenter randomized controlled trial for rhG-CSF in the treatment of
novel coronavirus pneumonia (COVID-19) 重组人粒细胞集落刺激因子治疗新型冠
状病毒肺炎(COVID-19)的多中心临床随机对照研究 Multicenter randomized
controlled trial for rhG-CSF in the treatment of novel coronavirus pneumonia
(COVID-19) 2/3/2020
182 ChiCTR2000030008 2/19/2020 中山大学附属第五医院 The Fifth
Affiliated Hospital of Sun Yat-Sen University 新型冠状病毒 (COVID-19) 流
行期间医护人员焦虑、抑郁水平与肠道菌群相关性研究 Correalation between
anxiety as well as depression and gut microbiome among staff of hospital
during the novel coronavirus pneumonia (COVID-19) outbreak 2/12/2020
183 ChiCTR2000030010 2/19/2020 武汉市金银潭医院（武汉市传染病医院）
Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital) 一项评
价抗SARS-CoV-2病毒灭活血浆治疗重型新型冠状病毒感染患者(COVID-19)的有效性及安
全性的随机、双盲、平行对照、单中心临床研究 A randomized, double-blind,
parallel-controlled, trial to evaluate the efficacy and safety of anti-SARS-
CoV-2 virus inactivated plasma in the treatment of severe novel coronavirus
pneumonia patients (COVID-19) 2/19/2020
184 ChiCTR2000030012 2/19/2020 郴州市第一人民医院南华大学转化医学研
究所 The First People's Hospital of Chenzhou, Institute of Translational
Medicine,University of South China 新型冠状病毒(COVID-19)治疗性抗体研发
Development of anti-2019-nCoV therapeutic antibody from the recovered
novel coronavirus pneumonia patients (COVID-19) 2/19/2020
185 ChiCTR2000030013 2/20/2020 中国人民解放军总医院 Chinese PLA
General Hospital 重组人干扰素α1b喷雾剂预防高暴露医护人员感染新型冠状病毒
(COVID-19)的前瞻性临床研究 A prospective clinical study for recombinant
human interferon alpha 1b spray in the prevention of novel coronavirus (
COVID-19) infection in highly exposed medical staffs. 2/20/2020
186 ChiCTR2000030014 2/20/2020 武汉市第四医院 Wuhan Fourth
Hospital 早期肺康复训练对新型冠状病毒肺炎(COVID-19)患者肺功能和生活质量的
影响 Effect of early pulmonary training on lung function and quality of
life for novel coronavirus pneumonia (COVID-19) patients 2/19/2020
187 ChiCTR2000030015 2/20/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital,Tongji Medical College, Huazhong University of Science and
Technology 女性新型冠状病毒肺炎(COVID-2019)的发病和转归与卵巢功能的相关
性研究 Study for the correlation between the incidence and outcome of
novel coronary pneumonia (COVID-2019) and ovarian function in women 2/19/
2020
188 ChiCTR2000030016 2/20/2020 北海市人民医院/广西医科大学第一附属
医院呼吸内科 Beihai People's Hospital/Department of respiratory medicine,
the First Affiliated Hospital of Guangxi Medical University 雾化吸入灭活
分枝杆菌疫苗治疗新冠病毒感染性肺炎(COVID-19)的基础与临床研究 Basic and
clinical study of inhalation of inactivated mycobacterium vaccine in the
treatment of Novel coronavirus pneumonia (COVID-19) 2/4/2020
189 ChiCTR2000030017 2/20/2020 武汉大学人民医院 Renmin Hospital
of Wuhan University 多脏器超声特征性改变在新型冠状病毒肺炎(COVID-19)临床
进展和预后评估中的价值 Feature of Multiple Organs in Ultrasound
Investigation for Clinical Management and Prognostic Evaluation of Novel
Coronavirus Pneumonia (COVID-19) 2/17/2020
190 ChiCTR2000030019 2/20/2020 复旦大学附属中山医院 Zhongshan
Hospital Fudan University 基于移动终端观察新型冠状病毒肺炎(COVID-19)患者
的前瞻性注册研究 The COVID-19 Mobile Health Study (CMHS), a large-scale
clinical observational registration study using nCapp 2/28/2020
191 ChiCTR2000030020 2/20/2020 南华大学附属第二医院 Second
Hospital of University of South China, Hengyang 间充质干细胞治疗新型冠状
病毒肺炎(COVID-19)的临床应用及其相关基础研究 The clinical application and
basic research related to mesenchymal stem cells to treat novel coronavirus
pneumonia (COVID-19) 2/6/2020
192 ChiCTR2000030021 2/20/2020 华中科技大学同济医学院附属同济医院呼
吸与危重症医学科 Department of Respiratory and Critical Care Medicine,
Tongji Hospital, Tongji Medical College, Huazhong University of Science and
Technology 免疫受损患者新型冠状病毒肺炎(COVID-19)临床特征：基于病历记录的
回顾性分析 A medical records based analysis for the clinical
characteristics of novel coronavirus pneumonia (COVID-19) in
immunocompromised patients 1/26/2020
193 ChiCTR2000030022 2/20/2020 安徽医科大学第一附属医院 First
Affiliated Hospital of Anhui Medical University 含吐根酊小儿化痰止咳颗粒
治疗轻型及普通型冠状病毒肺炎(COVID-19)的有效性和安全性研究：一项平行、随机对
照临床试验 A parallel, randomized controlled clinical trial for the
efficacy and safety of Pediatric Huatanzhike granules (containing
ipecacuanha tincture) in the treatment of mild and moderate novel
coronavirus pneumonia (COVID-19) 2/20/2020
194 ChiCTR2000030027 2/20/2020 北京中医药大学东直门医院
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,
Beijing China 中西医结合治疗重型新型冠状病毒肺炎(COVID-19)的临床研究
Traditional Chinese medicine cooperative therapy for patients with Novel
coronavirus pneumonia (COVID-19) and its effect on spermatogenesis: a
randomized controlled trial 2/20/2020
195 ChiCTR2000030028 2/20/2020 四川大学华西医院 West China
Hospital, Sichuan University PD-1单抗用于治疗新型冠状病毒肺炎(COVID-19)重
型或危重型患者的临床对照研究 Clinical comparative study of PD-1 mAb in
the treatment of severe and critical patients with novel coronavirus
pneumonia (COVID-19) 2/24/2020
196 ChiCTR2000030029 2/21/2020 浙江大学医学院附属第一医院 The
First Affiliated Hospital of Zhejiang University School of Medicine 评价
注射用苏拉明钠在新型冠状病毒肺炎(COVID-19)患者的疗效和安全性的临床研究 A
multi-center study on the efficacy and safety of suramin sodium in adult
patients with novel coronavirus pneumonia (COVID-19) 2/20/2020
197 ChiCTR2000030030 2/21/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital, Tongji Medical College, Huazhong University of Science
and Technology 新型冠状病毒肺炎（COVID-19）患者急性肾损伤：基于病历记录的
分析 A medical records based study for acute kidney injury in novel
coronavirus pneumonia (COVID-19) 2/20/2020
198 ChiCTR2000030031 2/21/2020 广州医科大学附属第六医院（清远市人民
医院） The Sixth Affiliated Hospital of Guangzhou Medical University (
Qingyuan People's Hospital) 磷酸氯喹片联合标准疗法对比标准疗法治疗轻型/普
通型2019冠状病毒肺炎（COVID-19）的随机、双盲、平行对照研究 A randomized,
double-blind, parallel, controlled trial for comparison of phosphoric
chloroquine combined with standard therapy and standard therapy in mild/
common patients with novel coronavirus pneumonia (COVID-19) 2/20/2020
199 ChiCTR2000030032 2/21/2020 西安市胸科医院 Xi'an Chest
Hospital 非重症期新型冠状病毒肺炎（COVID-19）肺周病变超声影像学表现：基于
病历记录的研究 A medical records based study for ultrasonographic
manifestations of new type of novel coronavirus pneumonia (covid-19) in non-
critical stage of pulmonary lesions 2/10/2020
200 ChiCTR2000030033 2/21/2020 广州医科大学附属第一医院 The
First Affiliated Hospital of Guangzhou Medical University 香雪抗病毒口服
液和五指防冠方对新型冠状病毒肺炎(COVID-19)密切接触者干预的研究 A study
for the intervention of Xiangxue antiviral oral solution and Wu-Zhi-Fang-
Guan-Fang on close contacts of novel coronavirus pneumonia (COVID-19) 2/
24/2020
201 ChiCTR2000030034 2/21/2020 浙江省立同德医院 Tongde Hospital
of Zhejiang Province 中医药治疗新型冠状病毒肺炎(COVID-19)的临床研究
Traditional Chinese Medicine in the treatment of novel coronavirus pneumonia
(COVID-19): a multicentre, randomized controlled trial 2/7/2020
202 ChiCTR2000030039 2/21/2020 徐州医科大学附属医院 Affiliated
Hospital of Xuzhou Medical University 输注康复者恢复期血浆治疗新型冠状病
毒肺炎(COVID-19)患者的临床研究 Clinical study for infusing convalescent
plasma to treat patients with new coronavirus pneumonia (COVID-19) 5/31/
2020
203 ChiCTR2000030041 2/21/2020 武汉大学中南医院 Zhongnan
Hospital of Wuhan University 阿兹夫定片治疗成人新型冠状病毒肺炎(COVID-19
)的单臂、单中心临床试验 A single-arm, single-center clinical trial for
Azivudine tablets in the treatment of adult novel coronavirus pneumonia (
COVID-19) 2/25/2020
204 ChiCTR2000030042 2/21/2020 重庆垫江县人民医院 Chongqing
Dianjiang County People's Hospital 新型冠状病毒肺炎(COVID-19)诊断预测模型
构建：多中心回顾性研究 A Medical Records Based Study for Construction and
Analysis of Diagnosis Predictive Model of Novel Coronavirus Pneumonia (
COVID-19) 2/21/2020
205 ChiCTR2000030043 2/21/2020 北京大学第三医院 Peking
University Third Hospital 参附注射液治疗新型冠状病毒重症肺炎(COVID-19)：
一项多中心、随机对照、开放标签临床研究 Shen-Fu injection in the treatment
of severe novel coronavirus pneumonia (COVID-19): a multicenter, randomized
, open-label, controlled trial 2/21/2020
206 ChiCTR2000030046 2/21/2020 武汉市江夏区第一人民医院（协和江南医
院） First People's Hospital of Jiangxia District, Wuhan (Union Jiangnan
Hospital) 一项评价抗2019-nCoV病毒灭活血浆治疗新型冠状病毒肺炎(COVID-19)患
者的有效性及安全性的单臂、开放临床研究 A single arm trial to evaluate the
efficacy and safety of anti-2019-nCoV inactivated convalescent plasma in
the treatment of novel coronavirus pneumonia patient (COVID-19) 2/7/2020
207 ChiCTR2000030054 2/22/2020 厦门大学附属中山医院 Zhongshan
Hospital Affiliated to Xiamen University 磷酸氯喹/硫酸羟氯喹在轻症和普通
型新型冠状病毒肺炎(COVID-19)患者的前瞻性开放性随机对照试验 A prospective,
open label, randomized, control trial for chloroquine or hydroxychloroquine
in patients with mild and common novel coronavirus pulmonary (COVIP-19)
2/22/2020
208 ChiCTR2000030055 2/22/2020 广州医科大学附属第一医院 The
First Affiliated Hospital of Guangzhou Medical University 双嘧达莫（商品
名：潘生丁）防治新型冠状病毒性肺炎(COVID-19)的临床多中心研究 Multicenter
study for the treatment of Dipyridamole with novel coronavirus pneumonia (
COVID-19) 2/10/2020
209 ChiCTR2000030056 2/22/2020 华中科技大学同济医学院附属协和医院
Union Hospital, Tongji Medical College, Huazhong University of Science &
Technology 早期气管插管对新型冠状病毒肺炎(COVID-19)患者转归影响的研究
Study for the effect of early endotracheal intubation on the outcome of
novel coronavirus pneumonia (COVID-19) patients 2/23/2020
210 ChiCTR2000030058 2/22/2020 武汉大学人民医院 Renmin Hospital
of Wuhan University 来氟米特对新型冠状病毒肺炎(COVID-19)治疗的 多中心、随
机、双盲、对照性临床试验 A multicenter, randomized, double-blind,
controlled clinical trial for leflunomide in the treatment of novel
coronavirus pneumonia (COVID-19) 3/10/2020
211 ChiCTR2000030082 2/22/2020 南昌大学第一附属医院 The First
Affiliated Hospital of Nanchang University 双氢青蒿素哌喹治疗轻型/普通型
新型冠状病毒肺炎(COVID-19)的临床疗效评价 Randomized controlled trial for
the efficacy of dihydroartemisinine piperaquine in the treatment of mild/
common novel coronavirus pneumonia (COVID-19) 2/23/2020
212 ChiCTR2000030084 2/22/2020 山西医科大学第一医院 The First
Hospital of Shanxi Medical University “智能化心身调节系统”干预新型冠状
病毒肺炎（COVID-19）患者伴发轻中度焦虑抑郁状态的多中心临床疗效研究 A
multicenter study for efficacy of intelligent psychosomatic adjustment
system intervention in the treatment of novel coronavirus pneumonia (COVID-
19) patients with mild to moderate anxiety and depression 2/24/2020
213 ChiCTR2000030085 2/22/2020 遵义医科大学附属医院 Affiliated
Hospital of Zunyi Medical University 新型冠状病毒 (COVID-19) IgM/IgG抗体
检测试剂盒在不同住院患者人群中的假阳性率研究 Study for the false positive
rate of IgM / IgG antibody test kit for novel coronavirus pneumonia (COVID-
19) in different inpatients 2/22/2020
214 ChiCTR2000030086 2/22/2020 华中科技大学同济医学院附属协和医院
Union Hospital, Tongji Medical College, Huazhong University of Science &
Technology 对于新型冠状病毒肺炎(COVID-19)产妇采用不同麻醉方案对医护感染率
及心理健康情况的影响 A medical records based study for the impacting on
medical providers' infection rate and mental health after performing
different anesthesia schemes in cesarean section for novel coronavirus
pneumonia (COVID-19) puerperae 2/24/2020
215 ChiCTR2000030087 2/22/2020 华中科技大学同济医学院附属协和医院
Union Hospital, Tongji Medical College, Huazhong University of Science and
Technology 新型冠状病毒肺炎(COVID-19)肺超声诊断价值临床研究 Clinical
study for the diagnostic value of pulmonary ultrasound for novel coronavirus
pneumonia (COVID-19) 2/12/2020
216 ChiCTR2000030088 2/23/2020 解放军总医院第六医学中心 The
Sixth Medical Center of PLA General Hospital 脐带华通胶源间充质干细胞治疗
重症新型冠状病毒肺炎(COVID-19) Umbilical cord Wharton's Jelly derived
mesenchymal stem cells in the treatment of severe novel coronavirus
pneumonia (COVID-19) 3/1/2020
217 ChiCTR2000030089 2/23/2020 上海长征医院 Shanghai Changzheng
Hospital 格乐立（阿达木单抗）治疗新型冠状病毒肺炎（COVID-19）重型和危重型
患者的安全性和有效性的临床研究 A clinical study for the efficacy and
safety of Adalimumab Injection in the treatment of patients with severe
novel coronavirus pneumonia (COVID-19) 2/28/2020
218 ChiCTR2000030090 2/23/2020 四川大学华西医院 West China
Hospital, Sichuan University 大学生新冠状病毒肺炎(COVID-19)期间居家运动处
方干预前瞻性随机对照研究 A Prospective Randomized Controlled Trial for
Home Exercise Prescription Intervention During Epidemic of Novel Coronary
Pneumonia (COVID-19) in College Students 2/22/2020
219 ChiCTR2000030091 2/23/2020 四川大学华西医院 West China
Hospital, Sichuan University 护理专业学生新冠状病毒肺炎(COVID-19)流行期间
居家运动处方干预前瞻性随机对照研究 A prospective randomized controlled
trial for the home exercise prescription intervention in nursing students
during epidemic of novel coronary pneumonia (COVID-19) 2/22/2020
220 ChiCTR2000030092 2/23/2020 华中科技大学同济医学院附属协和医院
Union Hospital, Tongji Medical College, Huazhong University of Science &
Technology 超声心动图及其新技术评估新型冠状病毒肺炎(COVID-19)患者心脏功能
变化临床研究 Assessment of cardiac function in patients with Novel
Coronavirus Pneumonia (COVID-19) by echocardiography and its new techniques
2/12/2020
221 ChiCTR2000030093 2/23/2020 山西医科大学第二医院 The Second
Hospital of Shanxi Medical University 简化认知行为疗法对新型冠状病毒肺炎(
COVID-19)相关紧急心理应激反应的应用研究 Study for application of
simplified cognitive-behavioral therapy for related emergency psychological
stress reaction of medical providers working in the position of treatment
and control of novel coronavirus pneumonia (COVID-19) 3/1/2020
222 ChiCTR2000030094 2/23/2020 成都中医药大学 Chengdu University
of Traditional Chinese Medicine 新型冠状病毒肺炎（COVID-19）疫情对不同年
龄段女性月经、体质及心理状态的影响 Effects of novel coronavirus pneumonia
(COVID-19) on menstruation, TCM body construction and psychological state
for female at different ages 3/1/2020
223 ChiCTR2000030095 2/23/2020 南昌大学第一附属医院 The First
Affiliated Hospital of Nanchang University 新型冠状病毒肺炎(COVID-19)综合
诊疗方法的优化和评价以及重症发生的危险因素评估：基于病历记录的研究 A
medical records based study for optimization and evaluation of the
comprehensive diagnosis and treatment of novel coronavirus pneumonia (COVID-
19) and the assessment of risk factors for severe pneumonia 2/22/2020
224 ChiCTR2000030096 2/23/2020 北京大学第一医院 Peking
University First Hospital 建立新型病毒肺炎(COVID-19)病毒学动态变化和临床
特点相关性的研究 Study for establishment of correlation between
virological dynamics and clinical features in noveal coronavirus pneumonia (
COVID-19) 2/17/2020
225 ChiCTR2000030113 2/23/2020 深圳市第三人民医院 Clinical study
for safety and efficacy of Favipiravir in the treatment of novel
coronavirus pneumonia (COVID-19) with poorly responsive ritonavir/ritonavir
法匹拉韦治疗洛匹那韦/利托那韦应答不佳的新型冠状病毒肺炎(COVID-19)患者的有
效性与安全性的临床研究 Randomized controlled trial for safety and
efficacy of Favipiravir in the treatment of novel coronavirus pneumonia (
COVID-19) with poorly responsive ritonavir/ritonavir 2/22/2020
226 ChiCTR2000030114 2/23/2020 北京大学人民医院 Peking
University People's Hospital 肺部超声在新型冠状病毒肺炎(COVID-19)肺部病变
诊断、治疗和预后中的研究 Lung ultrasound in the diagnosis, treatment and
prognosis of pulmonary lesions of novel coronavirus pneumonia (COVID-19)
2/24/2020
227 ChiCTR2000030115 2/23/2020 华中科技大学同济医学院附属同济医院
Tongji Hospital, Tongji Medical College, Huazhong University of Science
and Technology 血皮质醇ACTH及肾上腺形态变化指导重症新冠状病毒肺炎(COVID-
19)患者个体化激素应用临床研究 A clinical research for the changes of
Blood cortisol ACTH level and adrenal morphology in blood cortisol to guide
the application of individualized hormone in severe novel coronavirus
pneumonia (COVID-19) patients 2/27/2020
228 ChiCTR2000030116 2/23/2020 南昌大学第一附属医院 The First
Affiliated Hospital of Nanchang University 人脐带间充质干细胞治疗重症新型
冠状病毒肺炎（COVID-19）致急性呼吸窘迫综合征的安全性和有效性研究 Safety
and effectiveness of human umbilical cord mesenchymal stem cells in the
treatment of acute respiratory distress syndrome of severe novel coronavirus
pneumonia (COVID-19) 2/1/2020
229 ChiCTR2000030117 2/23/2020 江西青峰药业有限公司 Jiangxi
Qingfeng Pharmaceutical Co., Ltd. 喜炎平注射液联合常规治疗治疗普通型新型
冠状病毒感染肺炎（COVID-19）评价有效性和安全性的前瞻性、随机、开放、平行对照
、多中心临床研究 A multicenter, randomized, open, parallel controlled
trial for the evaluation of the effectiveness and safety of Xiyanping
injection in the treatment of common type novel coronavirus pneumonia (COVID
-19) 2/15/2020
230 ChiCTR2000030118 2/23/2020 深圳市国医传承医学研究院有限公司
Shenzhen national medicine inheritance medical research institute co. LTD
“火神颗粒”治疗新型冠状病毒肺炎(COVID-19)临床研究 A clinical study for
''Huo-Shen'' particles in the treatment of novel coronavirus pneumonia (
COVID-19) 2/24/2020
231 ChiCTR2000030135 2/24/2020 西安交通大学第二附属医院 The
Second Affiliated Hospital of Xi'an Jiaotong University 大剂量维生素C治疗
重型及危重型新型冠状病毒肺炎（COVID-19）的随机对照临床研究 A randomized
controlled trial for high-dose Vitamin C in the treatment of severe and
critical novel coronavirus pneumonia (COVID-19) patients 2/25/2020
232 ChiCTR2000030136 2/24/2020 西安交通大学第二附属医院 The
Second Affiliated Hospital of Xi'an Jiaotong University 人文关怀方案在新
型冠状病毒肺炎(COVID-19)救治中作用的临床研究 Humanistic Care in Patients
With Novel Coronavirus Pneumonia (COVID-19) 2/25/2020
233 ChiCTR2000030137 2/24/2020 西安交通大学第二附属医院 The
Second Affiliated Hospital of Xi'an Jiaotong University 人文关怀方案对新
型冠状病毒肺炎(COVID-19)救治中医护人员保护作用的观察性研究 Humanistic
Care in Healthcare Workers in Novel Coronavirus Pneumonia (COVID-19) 2/25
/2020
234 ChiCTR2000030138 2/24/2020 中国人民解放军总医院 Chinese PLA
General Hospital 人间充质干细胞治疗重症新型冠状病毒（COVID-19）感染肺炎临
床研究 Clinical Trial for Human Mesenchymal Stem Cells in the Treatment
of Severe Novel Coronavirus Pneumonia (COVID-19) 2/24/2020
235 ChiCTR2000030162 2/24/2020 武汉大学中南医院 Zhongnan
Hospital of Wuhan University 大豆水提物对新型冠状病毒肺炎 (COVID-19) 的临
床治疗研究 Study for the water extract of soybean in the treatment of
patients with novel coronavirus pneumonia (COVID-19) 2/5/2020
236 ChiCTR2000030163 2/24/2020 上海中医药大学附属岳阳中西医结合医院
Yueyang Hospital of Integrated Traditional Chinese Medicine and Western
Medicine Affiliated to Shanghai University of Tranditional Medicine 新型
冠状病毒肺炎(COVID-19)中医综合干预疗效：基于病历记录的回顾性真实世界研究
A Medical Based Retrospective Real World Study for Assessment of
Effectiveness of Comprehensive Traditional Chinese Medicine in the treatment
of Novel Coronavirus Pneumonia (COVID-19) 2/25/2020
237 ChiCTR2000030164 2/24/2020 华中科技大学同济医学院附属协和医院
Union Hospital, Tongji Medical College, Huazhong University of Science and
Technology ICU新型冠状病毒肺炎(COVID-19)横断面研究 A cross-sectional
study of novel coronavirus pneumonia (COVID-19) patients in ICU 2/24/2020
238 ChiCTR2000030165 2/24/2020 天津大学海河医院 Haihe hospital,
Tianjin University 医用三氧自体血疗法治疗新冠病毒肺炎(COVID-19)患者的临床
研究 Clinical study for ozonated autohemotherapy in the treatment of
Novel Coronavirus Pneumonia (COVID-19) 2/24/2020
239 ChiCTR2000030166 2/24/2020 解放军总医院第五医学中心 The 5th
Medical Center Chinese PLA General Hospital 清瘟败毒饮联合抗病毒疗法治疗
新型冠状病毒肺炎(COVID-19)的临床研究：随机、平行对照、开放性试验
Randomized, parallel control, open trial for Qing-Wen Bai-Du-Yin combined
with antiviral therapy in the treatment of novel coronavirus pneumonia (
COVID-19) 2/25/2020
240 ChiCTR2000030167 2/24/2020 武汉大学人民医院 Renmin Hospital
of Wuhan University 重组人白介素2治疗新型冠状病毒(COVID-19)肺炎的临床研究
Clinical Trial for Recombinant Human Interleukin-2 in the Treatment of
Novel Coronavirus Pneumonia (COVID-19) 3/2/2020
241 ChiCTR2000030168 2/24/2020 南京中医药大学附属中西医结合医院
Affiliated Hospital of traditional Chinese and Western Medicine Nanjing
University of Chinese Medicine 复方鱼腥草合剂预防新型冠状病毒肺炎(COVID-
19)的真实世界研究 A real world study for Compound Houttuyniae Mixture for
prevention of novel coronavirus pneumonia (COVID-19) 2/29/2020
242 ChiCTR2000030170 2/24/2020 上海市公共卫生临床中心 Shanghai
Public Health Clinical Center 盐酸杰克替尼片治疗重型和急性加重期新型冠状
病毒肺炎(COVID-19)患者过度炎症反应有效性和安全性的单臂、开放、单中心临床研究
Study for safety and efficacy of Jakotinib hydrochloride tablets in the
treatment severe and acute exacerbation patients of novel coronavirus
pneumonia (COVID-19) 2/15/2020
243 ChiCTR2000030173 2/24/2020 湖南源品细胞生物科技有限公司/南华大
学附属南华医院 Hu'nan Yuanpin Cell Biotechnology Co., Ltd/Nanhua Hospital
Affiliated to Nanhua University 脐带间充质干细胞治疗新型冠状病毒肺炎(
COVID-19)关键技术攻关与临床应用示范 Key techniques of umbilical cord
mesenchymal stem cells for the treatment of novel coronavirus pneumonia (
COVID-19) and clinical application demonstration 2/17/2020
244 ChiCTR2000030179 2/24/2020 南昌大学第一附属医院 The First
Affiliated Hospital of Nanchang University 新冠肺炎康复者恢复期血浆治疗
重症新冠肺炎(COVID-19)的实验研究 Experimental study of novel coronavirus
pneumonia rehabilitation plasma therapy severe novel coronavirus pneumonia (
COVID-19) 2/24/2020
245 ChiCTR2000030185 2/24/2020 四川大学华西医院重症医学科
Department of Critical Care Medicine, West China Hospital of Sichuan
University 重症超声在新型冠状病毒肺炎(COVID-19)患者快速筛检、确诊、效果
评判及重症化防治中的价值研究 The Value of Critical Care Ultrasound in
Rapid Screening, Diagnosis, Evaluation of Effectiveness and Intensive
Prevention of Novel Coronavirus Pneumonia (COVID-19) 2/24/2020
246 ChiCTR2000030187 2/24/2020 荆州市第一人民医院 Jingzhou First
People's Hospital 洛匹那韦利托那韦治疗新型冠状病毒肺炎(COVID-19)患者的临
床研究 Clinical study for Lopinavir and Ritonavir in the treatment of
novel coronavirus pneumonia (COVID-19) 2/25/2020
247 ChiCTR2000030188 2/24/2020 广东省中医院珠海医院 Guangdong
Provincial Hospital of Chinese Medicine - Zhuhai Hospital 中药复方辨证治
疗重型及危重型新型冠状病毒肺炎(COVID-19)的临床研究 Clinical Study on
Syndrome Differentiation of TCM in Treating Severe and Critical novel
coronavirus pneumonia (COVID-19) 2/15/2020
248 ChiCTR2000030196 2/25/2020 武汉大学中南医院 Central South
Hospital, Wuhan University 一项评估CMAB806治疗新型冠状病毒肺炎(COVID-19)
患者细胞因子释放综合征的疗效和安全性的单臂、开放、多中心临床试验 A
multicenter, single arm, open label trial for the efficacy and safety of
CMAB806 in the treatment of cytokine release syndrome of novel coronavirus
pneumonia (COVID-19) 2/20/2020
249 ChiCTR2000030198 2/25/2020 四川大学华西医院 West China
Hospital, Sichuan University 肺康复治疗对重型或者危重型新型冠状病毒肺炎(
COVID-19)治愈出院患者功能影响的临床研究 Clinical research of pulmonary
rehabilitation in survivors due to severe or critial novel coronavirus
pneumonia (COVID-19) 8/24/2020
250 ChiCTR2000030215 2/25/2020 南昌大学第一附属医院 The First
Affiliated Hospital of Nanchang University 抗冠1-3号方对新型冠状病毒感染
肺炎的临床功效试验 Study for the efficacy of Kangguan No. 1-3
prescription in the treatment of novel coronavirus pneumonia (COVID19) 2/
26/2020
251 ChiCTR2000030218 2/25/2020 赣州市第五人民医院 Fifth People's
Hospital of Ganzhou 匹那韦/利托那韦片（商品名: 克力芝）联合喜炎平注射液
治疗新型冠状病毒肺炎(COVID-19)评价研究 Study of Pinavir / Ritonavir
Tablets (Trade Name: Kelizhi) Combined with Xiyanping Injection for Novel
Coronavirus Pneumonia (COVID-19) 1/22/2020
252 ChiCTR2000030219 2/25/2020 天津中医药大学第一附属医院 First
Teaching Hospital of Tianjin University of Traditional Chinese Medicine
中西医结合干预新型冠状病毒肺炎(COVID-19)临床评价研究 Study for evaluation
of integrated traditional Chinese and Western Medicine in the treatment of
Novel Coronavirus Pneumonia (COVID-19) 1/21/2020
253 ChiCTR2000030221 2/25/2020 广州市番禺区中心医院 Central
Hospital of Panyu District, Guangzhou City 基层新型冠状病毒肺炎(COVID-19)
疑似病例收治医院工作人员睡眠状况的研究 Study for sleep status of medical
staffs of hospitals administrating suspected cases of Novel Coronavirus
Pneumonia (COVID-19) 1/31/2020
254 ChiCTR2000030222 2/25/2020 重庆市第十三人民医院 The
Thirteenth People's Hospital of Chongqing 新型冠状病毒肺炎(COVID-19)疫情
对老年人健康的影响 Study for the Impact of Novel Coronavirus Pneumonia (
COVID-19) to the Health of the elderly People 2/21/2020
255 ChiCTR2000030223 2/25/2020 香港中文大學賽馬會公共衛生與基層醫療
學院 JC School Of Public Health And Primary Care, The Chinese University
Of Hong Kong 新型冠狀病毒肺炎(COVID-19)暴發期間或之後中國居民的生活品質線
上調查 Quality of life among Chinese residents during and after novel
coronavirus pneumonia (COVID19) outbreak: an online survey 2/20/2020
256 ChiCTR2000030224 2/25/2020 华中科技大学同济医学院附属协和医院
Union Hospital, Tongji Medical College, Huazhong University of Science and
Technology 间充质干细胞治疗重症型新型冠状病毒肺炎(COVID-19)的临床研究
Clinical study of mesenchymal stem cells in treating severe novel
coronavirus pneumonia (COVID-19) 2/26/2020
257 ChiCTR2000030225 2/25/2020 上海中医药大学附属岳阳中西医结合医院
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,
Shanghai University of Traditional Chinese Medicine 针刺治疗新型冠状病毒
肺炎(COVID-19)临床应用研究 Clinical Reseach of Acupuncture in the
treatment of Novel Coronavirus Pneumonia (COVID-19) 2/22/2020
258 ChiCTR2000030226 2/25/2020 河北医科大学第四医院 The Fourth
Hospital of Hebei Medical University 河北省新型冠状病毒肺炎(COVID-19)重症
患者的治疗现状及预后相关危险因素研究 The treatment status and risk
factors related to prognosis of hospitalized patients with novel coronavirus
pneumonia (COVID-19) in intensive care unit, Hebei, China: a descriptive
study 2/1/2020
259 ChiCTR2000030253 2/26/2020 四川大学华西甘孜医院 Ganzi
Hospital of West China Hospital, Sichuan University 新型冠状病毒感染(
COVID-19)核酸检测新方法的探索和研究 Exploration and Research for a new
method for detection of novel coronavirus (COVID-19) nucleic acid 2/27/
2020
260 ChiCTR2000030254 2/26/2020 武汉大学中南医院 Zhongnan
Hospital of Wuhan University 法匹拉韦片治疗新型冠状病毒肺炎(COVID-19)的随
机、开放、对照临床研究 A randomized, open-controlled trial for farpiravir
tablets in the treatment of novel coronavirus pneumonia (COVID-19) 2/20/
2020
261 ChiCTR2000030255 2/26/2020 上海中医药大学 Shanghai
University of Traditional Chinese Medicine 评价荆银颗粒治疗新型冠状病毒肺
炎(COVID-19)风热证有效性和安全性的临床研究 Efficacy and Safety of Jing-
Yin Granule in the treatment of novel coronavirus pneumonia (COVID-19) wind-
heat syndrome 2/1/2020
262 ChiCTR2000030256 2/26/2020 陆军军医大学大坪医院 Daping
Hospital, Army Medical University 火神山医院新型冠状病毒肺炎(COVID-19)患
者流行病学特点、临床特征及预后：基于病历记录的研究 Medical records based
study for epidemic and clinical characteristics of hospitalized patients
with novel coronavirus pneumonia (COVID-19) in Huoshenshan hospital, Wuhan
3/31/2020
263 ChiCTR2000030257 2/26/2020 广东省第二人民医院/武汉市普仁医院
Guangdong Second Provincial General Hospital/Puren Hospital of Wuhan City
新型冠状病毒肺炎(COVID-19)患者的凝血功能研究 The coagulation function
of novel coronavirus pneumonia (COVID-19) patients 3/9/2020
264 ChiCTR2000030258 2/26/2020 哈尔滨医科大学附属第四医院 The
Fourth Affiliated Hospital of Harbin Medical University 氢气吸入治疗2019
新型冠状病毒肺炎(COVID-19)患者有效性和安全性的多中心、随机、对照临床研究
A multicenter, randomized, controlled trial for efficacy and safety of
hydrogen inhalation in the treatment of novel coronavirus pneumonia (COVID-
19) patients 2/21/2020
265 ChiCTR2000030259 2/26/2020 上海长征医院 Shanghai Changzheng
Hospital 评价达诺瑞韦钠片联合利托那韦治疗新型冠状病毒感染患者(COVID-19)的
疗效及安全性的随机、开放、对照临床研究 Evaluation Danorevir sodium
tablets combined with ritonavir in the treatment of novel coronavirus
pneumonia (COVID-19): a randomized, open and controlled trial 2/22/2020
266 ChiCTR2000030260 2/26/2020 四川大学华西甘孜医院 Ganzi
Hospital of West China Hospital, Sichuan University 个体化营养评估与支持
治疗对加速高原藏区新型冠状病毒肺炎(COVID-19)患者康复的临床和机制研究
Clinical study for individualized nutritional assessment and supportive
treatment of novel coronavirus pneumonia (COVID-19) patients in Tibetan
Plateau 2/27/2020
267 ChiCTR2000030261 2/26/2020 无锡市第五人民医院 Wuxi Fifth
People's Hospital 间充质干细胞外泌体雾化吸入治疗新型冠状病毒肺炎(COVID-19
)的关键技术研究 A study for the key technology of mesenchymal stem cells
exosomes atomization in the treatment of novel coronavirus pneumonia (COVID-
19) 3/1/2020
268 ChiCTR2000030262 2/26/2020 上海市公共卫生临床中心 Shanghai
Public Health Clinical Center 抗病毒药物+Ⅰ型IFN+抑炎因子TFF2联合应用治疗
新型冠状病毒感染(COVID-19)的临床研究 Clinical study for combination of
anti-viral drugs and type I interferon and inflammation inhibitor TFF2 in
the treatment of novel coronavirus pneumonia (COVID-19) 2/1/2020
269 ChiCTR2000030263 2/26/2020 北京老年医院 Beijing Geriatric
Hospital 新型冠状病毒肺炎(COVID-19)疫情期间医院工作者心理状况调查
Investigation and analysis of psychological status of hospital staff during
the novel coronavirus pneumonia (COVID-19) epidemic 2/20/2020
270 ChiCTR2000030264 2/26/2020 武汉大学中南医院重症医学科
Department of critical care, Zhongnan Hospital of Wuhan University 抗击新
型冠状病毒肺炎(COVID-19)期间ICU医护人员职业倦怠状况调查 ICU healthcare
personnel burnout investigation during the fight against novel coronavirus
pneumonia (COVID-19) 2/28/2020
271 ChiCTR2000030265 2/26/2020 哈尔滨医科大学附属第一医院 The
First Affiliated Hospital of Harbin Medical University 连续肾脏替代治疗配
套吸附性滤器用于治疗新型冠状病毒肺炎(COVID-19)的临床研究方案 Clinical
research program of continuous renal replacement therapy with adsorption
filter for the treatment of the novel coronavirus pneumonia (COVID-19) 2/
24/2020
【在 s********i 的大作中提到】
: 哪有其他药（不是治其他病的药，是治辽新冠的药）？都是谣传。。。世卫组织和中国
: 卫生部都明确说了没有药治疗新冠。。。因为第一个药一定是来自双盲实验。没有双盲
: 实验，都是扯淡啊。。。你说你吃这药好了，就算有效了？
| d*c
发帖数: 1 | 20 没经过双盲试验，所谓的部分有效就是扯淡。
我脚上搓的泥还部分有效呢，你吃不？
【在 g*q 的大作中提到】
: 多的是部分有效的药
| | | z*******4
发帖数: 285 | 21 大咪咪不吃屎，改吃脚泥了？
【在 d*c 的大作中提到】
: 没经过双盲试验，所谓的部分有效就是扯淡。
: 我脚上搓的泥还部分有效呢，你吃不？
| m****a
发帖数: 1 | 22 你能搞清楚有效药和特效药的区别吗
特效药是没有
有效药多的是
【在 s********i 的大作中提到】
: 哪有其他药（不是治其他病的药，是治辽新冠的药）？都是谣传。。。世卫组织和中国
: 卫生部都明确说了没有药治疗新冠。。。因为第一个药一定是来自双盲实验。没有双盲
: 实验，都是扯淡啊。。。你说你吃这药好了，就算有效了？
| s********i
发帖数: 17328 | 23 这些药经过双盲实验了吗？没经过双盲实验怎么证明的有效性呢？如果这些药物也用双
盲，那么为什么不骂这些药的实验者呢？这是基本逻辑问题，不是罗列些灌水文章就能
解释的。。。
blank-
【在 z*******4 的大作中提到】
: 算了，你脑子大概也被活摘过
: 懒得跟你解释，贴个清单吧：
: 累计研究数量 注册号 注册日期 研究者单位 研究者单位（英文） 注
: 册题目 注册题目（英文) 预计纳入参试者日期
: 1 ChiCTR2000029308 1/23/2020 武汉市金银潭医院（武汉市传染病医院）
: Wuhan Jinyintan Hospital (Wuhan Infectious Diseases Hospital) 一项评价
: 洛匹那韦/利托那韦和干扰素-α2b联合治疗武汉新型冠状病毒肺炎(COVID-19)住院患者
: 的疗效和安全性随机、开放、空白对照的研究 A randomized, open-label, blank-
: controlled trial for the efficacy and safety of lopinavir-ritonavir and
: interferon-alpha 2b in hospitalization patients with novel coronavirus
| s*********5
发帖数: 1 | 24 没有有效的药，所以为什么要对瑞德西尾特别照顾，可笑WHO采访了一个负责瑞德西尾
临床的人，就得出这个最有希望了，老将就开始舔。更可笑给吃安慰剂不倒霉，这不就
是老将嘴里有病不给治，在家等着死吗。
【在 s********i 的大作中提到】
: 哪有其他药（不是治其他病的药，是治辽新冠的药）？都是谣传。。。世卫组织和中国
: 卫生部都明确说了没有药治疗新冠。。。因为第一个药一定是来自双盲实验。没有双盲
: 实验，都是扯淡啊。。。你说你吃这药好了，就算有效了？
| s********i
发帖数: 17328 | 25 没有双盲实验，怎么证明有效呢？
【在 m****a 的大作中提到】
: 你能搞清楚有效药和特效药的区别吗
: 特效药是没有
: 有效药多的是
| z*******4
发帖数: 285 | 26 哎，贴出来了你都看不明白
这些不是论文，就是现在正在进行的、有批文的临床项目。
【在 s********i 的大作中提到】
: 这些药经过双盲实验了吗？没经过双盲实验怎么证明的有效性呢？如果这些药物也用双
: 盲，那么为什么不骂这些药的实验者呢？这是基本逻辑问题，不是罗列些灌水文章就能
: 解释的。。。
:
:
: blank-
| s********i
发帖数: 17328 | 27 你这句话没有回答我问的任何一个问题啊？这些药经过双盲实验了吗？没有双盲实验怎
么证明有效的？
【在 z*******4 的大作中提到】
: 哎，贴出来了你都看不明白
: 这些不是论文，就是现在正在进行的、有批文的临床项目。
| z*******4
发帖数: 285 | 28 你原来在纠结要不要双盲。。。。
简直是一群人在讨论汽车的性能，你在纠结马车。脑子是个好东西，时常带着点，不然
别人说什么你都听不明白
钟的说法跟双盲无关，关键是用什么做对照组。
一句话，瑞德西尾双盲实验如果用placebo做对照组，从新冠肺炎病人的角度说，是不
够人道的。
钟南山的指责，我是赞同的。
如钟所说，如果是双盲实验，但是用洛匹那韦/利托那韦，巴洛沙韦酯、法匹拉韦，甚
至其他已经有初步临床结果的中药做对照组，都更人道一些。
如果如钟南山这样设计的话，对病人更友好一些，但对吉力得没有任何好处，所以它们
用placebo做对照组
【在 s********i 的大作中提到】
: 你这句话没有回答我问的任何一个问题啊？这些药经过双盲实验了吗？没有双盲实验怎
: 么证明有效的？
| s********i
发帖数: 17328 | 29 任何一种药，不用placebo做对照组怎么证明他有效？参照药物的第一种药一定是用
placebo做对照组啊。。。你是不是吧placebo理解错了？用placebo不是不给你治疗的
意思，该输氧输氧，该打葡萄糖打葡萄糖啊。。。该用中药用中药（前提是中药对新冠
没有特别疗效）。
【在 z*******4 的大作中提到】
: 你原来在纠结要不要双盲。。。。
: 简直是一群人在讨论汽车的性能，你在纠结马车。脑子是个好东西，时常带着点，不然
: 别人说什么你都听不明白
: 钟的说法跟双盲无关，关键是用什么做对照组。
: 一句话，瑞德西尾双盲实验如果用placebo做对照组，从新冠肺炎病人的角度说，是不
: 够人道的。
: 钟南山的指责，我是赞同的。
: 如钟所说，如果是双盲实验，但是用洛匹那韦/利托那韦，巴洛沙韦酯、法匹拉韦，甚
: 至其他已经有初步临床结果的中药做对照组，都更人道一些。
: 如果如钟南山这样设计的话，对病人更友好一些，但对吉力得没有任何好处，所以它们
| d*c
发帖数: 1 | 30 你不是海归了么？还在这里扯什么蛋啊
【在 z*******4 的大作中提到】
: 大咪咪不吃屎，改吃脚泥了？
| | | z*******4
发帖数: 285 | 31 大规模上临床之前，都有一些前期数据
所以临床实验分一期二期三期
前期瑞德西尾怎么证明它有效的，其他药也是怎么证明的
瑞德西尾在美国刚治好了一例，就被吹上天了；
中国治好的何止百例千例，用的那些药，就不能用了？
还是那句话，从病人的角度考虑，用“那些药”做对照组，比用placebo更人道一些
但是对吉力得药厂而言，毫无益处，所以用placebo做对照组
道理太简单了，你还看不明白，就去找脑子吧，别再废话了
【在 s********i 的大作中提到】
: 任何一种药，不用placebo做对照组怎么证明他有效？参照药物的第一种药一定是用
: placebo做对照组啊。。。你是不是吧placebo理解错了？用placebo不是不给你治疗的
: 意思，该输氧输氧，该打葡萄糖打葡萄糖啊。。。该用中药用中药（前提是中药对新冠
: 没有特别疗效）。
| T*******x
发帖数: 8565 | 32 属实。诈欺。
【在 V*****2 的大作中提到】
: 还是应该可以告的，因为病人和病人家属并不懂得原理，属于欺诈行为。因为药物试验
: 可以使用比较试验，而不是用安慰剂做试验。
: 在任何有欺诈行为的情况下，尤其是直接危害病人生命的时候，签下的合同无效。这在
: 法律里讲得很清楚的。
| T*******x
发帖数: 8565 | 33 同意书就是欺诈。合同欺诈。
【在 z*******4 的大作中提到】
: 病人连自己是不是对照组都不知道，怎么告？
: 而且他们签字的同意书里，都放弃了许多的权利：
: 比如知道自己是药物组还是placebo组的权利；
: 比如治疗期间，选择其他药物治疗的权利；
: 比如治疗失败后，向药厂、医院索赔的权利。。。
: 简单来说，签了同意书，就是把命卖给药厂了
: 所以要找病人进组做临床实验，得忽悠，加大劲忽悠
: 但往往忽悠也凑不齐有脑子的病人
: 轮子这种脑子被活摘的病人，可能特别容易忽悠进组。
| T*******x
发帖数: 8565 | 34 不管有没有其他药。没把同意书解释到病人明白的程度，就可以告欺诈。
【在 s********i 的大作中提到】
: 哪有其他药（不是治其他病的药，是治辽新冠的药）？都是谣传。。。世卫组织和中国
: 卫生部都明确说了没有药治疗新冠。。。因为第一个药一定是来自双盲实验。没有双盲
: 实验，都是扯淡啊。。。你说你吃这药好了，就算有效了？
| s*********e
发帖数: 5245 | 35 你们都傻逼吗？
参加这种新药实验，都是你主动申请，药厂选择，有约在先，要随机安排新药和对照组
。新药可能对你有效，可能无效，也可能有严重副作用，无人可以保证，这也是协议告
知里的最重要部分。就象入股一个公司，你可能盈利，可能赔钱，弄不好还可能作为股
东被消费者起诉。你是完全自愿，也在
充分告知潜在的风险和益处前提下，没得到本来就是一个你自己预期的结果，就要起诉
人家。就象猥琐男泡贱逼，本来就
是两厢情愿，无人可以保证结局的事，你花费了两晚上，一炮没打上，是不是要起诉贱
逼导致你前列腺肿大？
一群傻逼还在争论这个毫无必要争论的东西。你麻痹逻辑都是习近平那娘的逼交给你们
的吗？
【在 z*******4 的大作中提到】
: 诸位称其为“良心公司”、“人民的希望”的将军们
: 要不要集体去药厂门口直播自焚？
|
|
